Search
Carcinoma, Non-Small-Cell Lung Clinical Trials
A listing of 41 Carcinoma, Non-Small-Cell Lung clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 12 of 41
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Carcinoma, Non-Small-Cell Lung
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
There are currently 41 active clinical trials seeking participants for Carcinoma, Non-Small-Cell Lung research studies. The states with the highest number of trials for Carcinoma, Non-Small-Cell Lung participants are California, Texas, Florida and New York.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.
Recruiting
The purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer therapies. Anti-cancer therapy is a type of treatment to stop the growth of cancer.
This study also aims to find the best amount of study medication.
This study is seeking participants who have solid tumors (a mass of abnormal cells that forms a lump or growth in the body) that:
* are advanced (cancer that doesn't disappear or stay away with treatment) a... Read More
The purpose of this study is to learn about the safety and effects of the study medicine when given alone or together with other anti-cancer therapies. Anti-cancer therapy is a type of treatment to stop the growth of cancer.
This study also aims to find the best amount of study medication.
This study is seeking participants who have solid tumors (a mass of abnormal cells that forms a lump or growth in the body) that:
* are advanced (cancer that doesn't disappear or stay away with treatment) and
* have a KRAS gene mutation (a change in the DNA of the KRAS gene that can cause cells to grow in very high numbers).
This includes (but limited to) the following cancer types:
* Non-Small Cell Lung Cancer (NSCLC): It's a type of lung cancer where the cells grow slowly but often spread to other parts of the body.
* Colorectal Cancer (CRC): This is a disease where cells in the colon (a part of large intestine) or rectum grow out of control.
* Pancreatic ductal adenocarcinoma (PDAC): This is a cancer that starts in the ducts of the pancreas but can spread quickly to other parts of the body. Pancreas is a long, flat gland that lies in the abdomen behind the stomach. Pancreas creates enzymes that help with digestion. It also makes hormones that can help control your blood sugar levels.
All participants in this study will take the study medication (PF-07985045) as pill by mouth once a day. This will be repeated for 21-day or 28-day cycles.
Depending on which part of the study participants are enrolled into they will receive the study medication (PF-07985045 alone or in combination with other anti-cancer medications). These anti-cancer medications will be given in the study clinic by intravenous (IV) that is directly injected into the veins at different times (depending on the treatment) during the 21-day or 28-day cycle.
Participants can continue to take the study medication (PF-07985045) and the combination anti-cancer therapy until their cancer is no longer responding.
The study will look at the experiences of people receiving the study medicines. This will help see if the study medicines are safe and effective.
Participants will be in this study for up to 4 years. During this time, the participants will come into the clinic for 1 to 4 times in each 21-day or 28-day cycle. After the participants have stopped taking the study medication (at about at 2 years) they will be followed for another two years to see how they are doing Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/30/2025
Locations: Highlands Oncology Group, Fayetteville, Arkansas +13 locations
Highlands Oncology Group, Fayetteville, Arkansas
Highlands Oncology Group, Rogers, Arkansas
Highlands Oncology Group, Springdale, Arkansas
City of Hope (City of Hope National Medical Center, City Of Hope Medical Center), Duarte, California
Brigham and Women's Hospital, Boston, Massachusetts
Dana-Farber Cancer Institute, Boston, Massachusetts
DFCI Chestnut Hill, Newton, Massachusetts
Columbia University Irving Medical Center, New York, New York
The University of Texas MD Anderson Cancer Center, Houston, Texas
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin
University of Wisconsin Carbone Cancer Center-University Hospital, Madison, Wisconsin
National Cancer Center Hospital East, Kashiwa, Chiba
Shizuoka Cancer Center, Nagaizumi-cho, Shizuoka
Pan American Center for Oncology Trials, LLC, Rio Piedras, Not set
Conditions: Carcinoma, Pancreatic Ductal, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Recruiting
The goal of this study is to learn if people who receive intismeran autogene and pembrolizumab after surgery are cancer-free longer than people who receive placebo and pembrolizumab. Researchers want to know if giving intismeran autogene and pembrolizumab after surgery can help prevent the cancer from coming back in people with non-small cell lung cancer (NSCLC) whose tumors did not respond completely to treatment before surgery (neoadjuvant treatment).
The goal of this study is to learn if people who receive intismeran autogene and pembrolizumab after surgery are cancer-free longer than people who receive placebo and pembrolizumab. Researchers want to know if giving intismeran autogene and pembrolizumab after surgery can help prevent the cancer from coming back in people with non-small cell lung cancer (NSCLC) whose tumors did not respond completely to treatment before surgery (neoadjuvant treatment). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/30/2025
Locations: Banner MD Anderson Cancer Center ( Site 0181), Gilbert, Arizona +151 locations
Banner MD Anderson Cancer Center ( Site 0181), Gilbert, Arizona
Providence St. Jude Medical Center ( Site 0106), Fullerton, California
UCSF Medical Center at Mission Bay ( Site 0178), San Francisco, California
UCHealth Memorial Hospital Central ( Site 0125), Colorado Springs, Colorado
Banner MD Anderson Cancer Center at North Colorado Medical Center ( Site 0207), Greeley, Colorado
Beacon Cancer Care ( Site 0127), Post Falls, Idaho
The University of Chicago Medical Center ( Site 0118), Chicago, Illinois
Massachusetts General Hospital ( Site 0136), Boston, Massachusetts
Dana Farber Cancer Hospital ( Site 0155), Boston, Massachusetts
Ellis Fischel Cancer Center ( Site 0133), Columbia, Missouri
Lake Regional Hospital-Cancer Center ( Site 0123), Osage Beach, Missouri
Montefiore Medical Center ( Site 0160), Bronx, New York
Roswell Park Cancer Institute ( Site 0184), Buffalo, New York
Hematology-Oncology Associates of CNY ( Site 0164), East Syracuse, New York
Icahn School of Medicine at Mount Sinai ( Site 0116), New York, New York
Memorial Sloan Kettering Cancer Center ( Site 0137), New York, New York
SUNY Upstate Cancer Center ( Site 0140), Syracuse, New York
Westchester Medical Center ( Site 0196), Valhalla, New York
University of Cincinnati Medical Center ( Site 0119), Cincinnati, Ohio
St. Lukes Hospital and Health Network ( Site 0186), Bethlehem, Pennsylvania
Thompson Cancer Survival Center ( Site 0168), Knoxville, Tennessee
MD Anderson Cancer Center ( Site 0150), Houston, Texas
Memorial Hermann Cancer Center ( Site 0172), Houston, Texas
O'Quinn Medical Tower at McNair Campus ( Site 0131), Houston, Texas
The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center ( Site 0148), Tyler, Texas
Swedish Cancer Institute ( Site 0143), Seattle, Washington
Virginia Mason Franciscan Health - St. Michael Cancer Center ( Site 0192), Silverdale, Washington
CEMIC ( Site 2454), Caba., Buenos Aires
Fundacion Intecnus ( Site 2456), San Carlos de Bariloche, Rio Negro
Centro Médico IPAM ( Site 2452), Rosario, Santa Fe
Instituto Medico Especializado Alexander Fleming ( Site 2457), Buenos Aires, Not set
Instituto Oncologico de Cordoba -IONC ( Site 2455), Cordoba, Not set
Calvary Mater Newcastle ( Site 2106), Waratah, New South Wales
Tasman Oncology Research ( Site 2104), Southport, Queensland
Princess Alexandra Hospital ( Site 2102), Wooloongabba, Queensland
Grampians Health ( Site 2101), Ballarat, Victoria
One Clinical Research ( Site 2103), Nedlands, Western Australia
Cliniques Universitaires Saint-Luc ( Site 1203), Bruxelles, Bruxelles-Capitale, Region De
Jessa Ziekenhuis ( Site 1204), Hasselt, Limburg
UZ Gent ( Site 1201), Gent, Oost-Vlaanderen
CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA ( Site 2502), Fortaleza, Ceara
Liga Norte Riograndense Contra o Cancer ( Site 2513), Natal, Rio Grande Do Norte
Hospital Tacchini ( Site 2506), Bento Goncalves, Rio Grande Do Sul
Hospital de Clínicas de Passo Fundo ( Site 2504), Passo Fundo, Rio Grande Do Sul
Hospital Moinhos de Vento ( Site 2510), Porto Alegre, Rio Grande Do Sul
Hospital Nossa Senhora Da Conceicao ( Site 2512), Porto Alegre, Rio Grande Do Sul
Instituto de Oncologia Saint Gallen ( Site 2507), Santa Cruz do Sul, Rio Grande Do Sul
Hospital de Amor - Barretos ( Site 2511), Barretos, Sao Paulo
Instituto Nacional de Câncer - INCA ( Site 2501), Rio de Janeiro, Not set
MBAL Uni Hospital ( Site 1253), Panagyurishte, Pazardzhik
MHAT - Heart and Brain ( Site 1252), Pleven, Not set
Queen Elizabeth II Health Sciences Centre ( Site 1101), Halifax, Nova Scotia
Hamilton Health Sciences - Juravinski Site ( Site 1104), Hamilton, Ontario
Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 1105), Kingston, Ontario
Lakeridge Health ( Site 1107), Oshawa, Ontario
McGill University Health Centre ( Site 1103), Montréal, Quebec
IUCPQ ( Site 1112), Québec, Quebec
FALP ( Site 2551), Santiago., Region M. De Santiago
Orlandi Oncologia ( Site 2555), Santiago, Region M. De Santiago
Clínica RedSalud Vitacura ( Site 2556), Santiago, Region M. De Santiago
Bradfordhill ( Site 2552), Santiago, Region M. De Santiago
ONCOCENTRO APYS ( Site 2554), Viña del Mar, Valparaiso
IMAT S.A.S ( Site 2602), Monteria, Cordoba
FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 2603), Bogota, Distrito Capital De Bogota
Hospital Universitario San Ignacio ( Site 2610), Bogota, Distrito Capital De Bogota
Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia ( Site 2604), Bogota, Distrito Capital De Bogota
Oncologos del Occidente ( Site 2608), Pereira, Risaralda
Fundacion Valle del Lili- CIC ( Site 2601), Cali, Valle Del Cauca
Oulun yliopistollinen sairaala ( Site 1301), Oulu, Pohjois-Pohjanmaa
Turku University Hospital ( Site 1303), Turku, Varsinais-Suomi
CHU Besançon ( Site 1358), Besancon, Franche-Comte
Institut De Cancerologie De L Ouest ( Site 1357), Saint Herblain, Loire-Atlantique
CENTRE LEON BERARD ( Site 1351), Lyon CEDEX 08, Rhone
Marienhaus Klinikum Mainz ( Site 1403), Mainz, Rheinland-Pfalz
UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 1452), Patras, Achaia
Errikos Dunant Hospital Center ( Site 1457), Athens, Attiki
THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 1451), Athens, Attiki
Metropolitan Hospital ( Site 1459), Athens, Attiki
ATTIKON GENERAL UNIVERSITY HOSPITAL ( Site 1460), Chaidari, Attiki
University General Hospital of Herakleion ( Site 1458), Herakleion., Irakleio
University General Hospital of Larissa-Oncology Clinic ( Site 1453), Larissa, Thessalia
Papageorgiou General Hospital of Thessaloniki ( Site 1454), Thessaloniki, Not set
Petz Aladár Megyei Oktató Kórház ( Site 1502), Gyor, Gyor-Moson-Sopron
Debreceni Egyetem Altalanos Orvostudomanyi Kar Tudogyogyaszati Tanszek ( Site 1508), Debrecen, Hajdu-Bihar
Mátrai Gyógyintézet ( Site 1504), Mátraháza, Heves
Reformatus Pulmonologiai Centrum-Onkopulmonologiai Jarobeteg Centrum ( Site 1505), Törökbálint, Pest
Somogy Vármegyei Kaposi Mór Oktató Kórház-Oncology center ( Site 1507), Kaposvár, Somogy
Orszagos Koranyi Pulmonologiai Intezet ( Site 1501), Budapest, Not set
Rambam Health Care Campus ( Site 1603), Haifa, Not set
Shaare Zedek Medical Center ( Site 1601), Jerusalem, Not set
Hadassah Medical Center ( Site 1605), Jerusalem, Not set
Sheba Medical Center ( Site 1602), Ramat Gan, Not set
Hospital of the University of Occupational and Environmental Health, Japan ( Site 1166), Kitakyushu, Fukuoka
St. Marianna University Hospital ( Site 1159), Kawasaki, Kanagawa
Kindai University Hospital ( Site 1162), Osakasayama, Osaka
National Cancer Center Hospital ( Site 1156), Chuo, Tokyo
Tokyo Medical University Hospital ( Site 1157), Shinjuku, Tokyo
Chiba University Hospital ( Site 1154), Chiba, Not set
National Hospital Organization Kyushu Cancer Center ( Site 1167), Fukuoka, Not set
Fukushima Medical University Hospital ( Site 1151), Fukushima, Not set
Hiroshima University Hospital ( Site 1165), Hiroshima, Not set
Wakayama Medical University Hospital ( Site 1163), Wakayama, Not set
National Cancer Center ( Site 2305), Goyang-si, Kyonggi-do
The Catholic University of Korea St. Vincent s Hospital ( Site 2301), Suwonsi, Kyonggi-do
Ajou University Hospital ( Site 2306), Suwon, Kyonggi-do
Seoul National University Hospital ( Site 2303), Seoul, Not set
Severance Hospital Yonsei University Health System ( Site 2302), Seoul, Not set
Samsung Medical Center ( Site 2304), Seoul, Not set
Seoul St. Mary's Hospital ( Site 2307), Seoul, Not set
Medisch Centrum Leeuwarden ( Site 1702), Leeuwarden, Fryslan
Radboudumc ( Site 1706), Nijmegen, Gelderland
Dunedin Hospital ( Site 2202), Dunedin, Otago
Aliada ( Site 2753), Lima, Not set
Detecta Clínica ( Site 2751), Lima, Not set
Krakowski Szpital Specjalistyczny im. Jana Pawla II ( Site 1756), Krakow, Malopolskie
Instytut Gruźlicy i Chorób Płuc w Warszawie ( Site 1764), Warszawa, Mazowieckie
Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1759), Przemysl, Podkarpackie
Uniwersyteckie Centrum Kliniczne ( Site 1758), Gdansk, Pomorskie
Swietokrzyskie Centrum Onkologii. ( Site 1754), Kielce, Swietokrzyskie
Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie ( Site 1760), Olsztyn, Warminsko-mazurskie
Wielkopolskie Centrum Pulmonologii i Torakochirurgii ( Site 1763), Poznan, Wielkopolskie
Centrul Medical Medicover Victoria ( Site 1802), Bucharest, Bucuresti
Institutul Regional de Oncologie ( Site 1804), Iasi, Not set
National Cancer Centre Singapore ( Site 2251), Singapore, Central Singapore
Tan Tock Seng Hospital ( Site 2252), Singapore, Central Singapore
Hospital Clinic de Barcelona ( Site 1919), Barcelona, Cataluna
Complejo Hospitalario Universitario A Coruna ( Site 1916), A Coruña, La Coruna
Hospital Universitario Quiron Madrid ( Site 1913), Pozuelo de Alarcon, Madrid
Hospital Insular de Gran Canaria ( Site 1911), Canarias, Not set
Hospital General Universitario Gregorio Maranon ( Site 1912), Madrid, Not set
Hospital Quiron Malaga ( Site 1914), Malaga, Not set
Karolinska Universitetssjukhuset Solna ( Site 1951), Stockholm, Stockholms Lan
Chung Shan Medical University Hospital ( Site 2351), Taichung, Not set
China Medical University Hospital ( Site 2358), Taichung, Not set
National Cheng Kung University Hospital ( Site 2354), Tainan, Not set
National Taiwan University Cancer Center (NTUCC) ( Site 2360), Taipei, Not set
Mackay Memorial Hospital ( Site 2355), Taipei, Not set
Taipei Medical University Hospital ( Site 2352), Taipei, Not set
Koo Foundation Sun Yat-Sen Cancer Center ( Site 2359), Taipei, Not set
Taipei Veterans General Hospital ( Site 2357), Taipei, Not set
Chang Gung Memorial Hospital ( Site 2361), Taoyuan, Not set
Hacettepe Universite Hastaneleri ( Site 2001), Sıhhiye, Ankara
Namık Kemal University Medical Faculty ( Site 2007), Tekirdag, Tekirdas
Ankara Bilkent Sehir Hastanesi ( Site 2002), Ankara, Not set
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi ( Site 2003), Istanbul, Not set
Bristol Haematology and Oncology Centre ( Site 2072), Bristol, Bristol, City Of
St Bartholomews Hospital ( Site 2052), London, London, City Of
Royal Free Hospital ( Site 2074), London, London, City Of
Guys Hospital ( Site 2057), London, London, City Of
Nottingham City Hospital ( Site 2058), Nottingham, Nottinghamshire
St James University Hospital ( Site 2055), Leeds, Not set
The Clatterbridge Cancer Centre ( Site 2069), Wirral, Not set
Conditions: Carcinoma, Non-Small-Cell Lung
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Recruiting
The purpose of the study is to compare how the new combination treatment (Sigvotatug Vedotin plus pembrolizumab) works compared to pembrolizumab alone in patients with non-small cell lung cancer (NSCLC) with high levels of PD-L1. This is a protein that acts as a kind of "brake" to keep the body's immune responses under control.
The study is seeking for participants who:
* Are confirmed to have NSCLC (Stage 3 or 4).
* Have PD-L1 levels in more than 50% of the cancer cells.
All participants in... Read More
The purpose of the study is to compare how the new combination treatment (Sigvotatug Vedotin plus pembrolizumab) works compared to pembrolizumab alone in patients with non-small cell lung cancer (NSCLC) with high levels of PD-L1. This is a protein that acts as a kind of "brake" to keep the body's immune responses under control.
The study is seeking for participants who:
* Are confirmed to have NSCLC (Stage 3 or 4).
* Have PD-L1 levels in more than 50% of the cancer cells.
All participants in this study will receive pembrolizumab at the study clinic once every 6 weeks as an intravenous (IV) infusion (give directly into a vein). In addition, half of the participants will also receive Sigvotatug Vedotin once every 2 weeks as an IV infusion in addition to receiving pembrolizumab.
Participants may receive pembrolizumab for up to about two years. Those participants taking Sigvotatug Vedotin can continue until their NSCLC is no longer responding. The study team will monitorsee how each participant is doing with the study treatment during regular visits at the clinic. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/30/2025
Locations: Mid Florida Hematology and Oncology Center, Orange City, Florida +45 locations
Mid Florida Hematology and Oncology Center, Orange City, Florida
BRCR Global, Plantation, Florida
Hope and Healing Cancer Services, Hinsdale, Illinois
Hope and Healing Cancer Services, New Lenox, Illinois
Jackson Oncology Associates, PLLC, Jackson, Mississippi
Jackson Oncology Associates, PLLC, Jackson, Mississippi
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Fremont, Fremont, Nebraska
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island, Grand Island, Nebraska
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Regional, Grand Island, Nebraska
Cancer Partners of Nebraska - April Sampson Cancer Center, Lincoln, Nebraska
Oncology Hematology West P.C. dba Nebraska Cancer Specialists - Methodist, Omaha, Nebraska
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Bergan, Omaha, Nebraska
Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha, Nebraska
Hematology Oncology Associates of Rockland, Nyack, New York
AZ Sint-Maarten, Mechelen, Antwerpen
UZ Brussel, Brussels, Bruxelles-capitale, Région DE
Algemeen Ziekenhuis klina, Brasschaat, Not set
Complex Oncology Center - Burgas, Burgas, Not set
MHAT for Women's Health Nadezhda, Sofia, Not set
Rabin Medical Center, Petah Tikva, Hamerkaz
Shaare Zedek Medical Center, Jerusalem, Yerushalayim
Gunma Prefectural Cancer Center, Otashi, Gunma
National Hospital Organization Asahikawa Medical Center, Asahikawa, Hokkaido
Kobe City Medical Center General Hospital, Kobe, Hyogo
Kanagawa cancer center, Yokohama, Kanagawa
Mie Chuo Medical Center, Tsu, MIE
Sendai Kousei Hospital, Sendai, Miyagi
NHO Kinki Chuo Chest Medical Center, Sakai, Osaka
The University of Osaka Hospital, Suita, Osaka
Nippon Medical School Hospital, Bunkyo-ku, Tokyo
National Cancer Center Hospital, Chuo-ku, Tokyo
The Cancer Institute Hospital of JFCR, Koto, Tokyo
National Hospital Organization Tokyo Medical Center, Meguro-Ku, Tokyo
Yamagata University Hospital, Yamagata-Shi, Yamagata
National Hospital Organization Kyushu Medical Center, Fukuoka, Not set
National Hospital Organization Kyushu Cancer Center, Fukuoka, Not set
National Hospital Organization Kyoto Medical Center, Kyoto, Not set
National Hospital Organization Okayama Medical Center, Okayama, Not set
St. Antonius Ziekenhuis, locatie Utrecht, Utrecht, Not set
Instytut Genetyki i Immunologii GENIM, Lublin, Lubelskie
Instytut MSF Sp zoo, Lodz, Łódzkie
Hospital General Universitario de Elche, Elche, Alicante
Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [barcelona]
Hospital Jerez de la Frontera, Jerez de la Frontera, Cádiz
Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad DE
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Not set
Conditions: Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
Recruiting
The purpose of this study is to learn about the safety and effects of the study medicine alone or when given together with other anti-cancer therapies. This study also aims to find the best dose.
This study is seeking participants who have solid tumors (a mass of abnormal cells that forms a lump or growth in the body) that:
* are advanced (cancer that doesn't disappear or stay away with treatment) and
* have a KRAS gene mutation (a change in the DNA of the KRAS gene that can cause cells to gro... Read More
The purpose of this study is to learn about the safety and effects of the study medicine alone or when given together with other anti-cancer therapies. This study also aims to find the best dose.
This study is seeking participants who have solid tumors (a mass of abnormal cells that forms a lump or growth in the body) that:
* are advanced (cancer that doesn't disappear or stay away with treatment) and
* have a KRAS gene mutation (a change in the DNA of the KRAS gene that can cause cells to grow in very high numbers).
This includes (but limited to) the following cancer types:
Non-Small Cell Lung Cancer (NSCLC): It's a type of lung cancer where the cells grow slowly but often spread to other parts of the body.
Colorectal Cancer (CRC): This is a disease where cells in the colon (a part of large intestine) or rectum grow out of control.
Pancreatic ductal adenocarcinoma (PDAC): This is a cancer that starts in the ducts of the pancreas but can spread quickly to other parts of the body. Pancreas is a long, flat gland that lies in the abdomen behind the stomach. Pancreas creates enzymes that help with digestion. It also makes hormones that can help control your blood sugar levels.
All participants in this study will take the study medication (PF-07934040) as pill by mouth twice a day repeating for 21-day or 28-day cycles.
Depending on which part of the study participants are enrolled into they will receive the study medication (PF-07934040 alone or in combination with other anti-cancer medications). These anti-cancer medications will be given in the study clinic by intravenous (IV) that is directly injected into the veins at various times (depending on the treatment) during the 21-day or 28-day cycle.
Participants can continue to take the study medication (PF-07934040) and the combination anti-cancer therapy until their cancer is no longer responding.
The study will look at the experiences of people receiving the study medicines. This will help see if the study medicines are safe and effective.
Participants will be involved in this study for up to 4 years. During this time, they will come into the clinic between 1 to 4 times in each 21-day or 28-day cycle. After they have stopped taking the study medication (at about at 2 years) they will be followed for another two years to see how they are doing. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/29/2025
Locations: Highlands Oncology Group, PA, Fayetteville, Arkansas +25 locations
Highlands Oncology Group, PA, Fayetteville, Arkansas
Highlands Oncology Group, PA, Rogers, Arkansas
Highlands Oncology Group, Springdale, Arkansas
City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte, California
City of Hope Investigational Drug Service (IDS), Duarte, California
University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP), Aurora, Colorado
University of Colorado Hospital - Anschutz Outpatient Pavilion, Aurora, Colorado
University of Colorado Hospital- Anschutz Cancer Pavilion (ACP), Aurora, Colorado
University of Colorado Hospital, Aurora, Colorado
START Midwest, Grand Rapids, Michigan
Siteman Cancer Center - West County, Creve Coeur, Missouri
Siteman Cancer Center - North County, Florissant, Missouri
Siteman Cancer Center, Saint Louis, Missouri
Barnes-Jewish Hospital, Saint Louis, Missouri
Washington University School of Medicine, Saint Louis, Missouri
Siteman Cancer Center - South County, Saint Louis, Missouri
Siteman Cancer Center - St Peters, Saint Peters, Missouri
Duke University Medical Center, lnvestigational Chemotherapy Service, Durham, North Carolina
Duke University Medical Center, Durham, North Carolina
University of Cincinnati Medical Center, Cincinnati, Ohio
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio
West Chester Hospital, West Chester, Ohio
Rhode Island Hospital, Providence, Rhode Island
Miriam Hospital, Providence, Rhode Island
University of Texas MD Anderson Cancer Center, Houston, Texas
Pan American Center for Oncology Trials, LLC, Rio Piedras, Not set
Conditions: Carcinoma, Pancreatic Ductal, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung
A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)
Recruiting
The purpose of this study is to evaluate the efficacy and safety of repotrectinib and crizotinib in participants with locally advanced or metastatic TKI-naïve ROS1-positive non-small cell lung cancer (NSCLC).
The purpose of this study is to evaluate the efficacy and safety of repotrectinib and crizotinib in participants with locally advanced or metastatic TKI-naïve ROS1-positive non-small cell lung cancer (NSCLC). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/24/2025
Locations: Local Institution - 0136, Augusta, Georgia +143 locations
Local Institution - 0136, Augusta, Georgia
Local Institution - 0221, Des Moines, Iowa
Massachusetts General Hospital, Boston, Massachusetts
Beth Israel Deaconess Medical Center, Boston, Massachusetts
Local Institution - 0217, Brooklyn, New York
Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola, New York
Laura and Isaac Perlmutter Cancer Center, New York, New York
Local Institution - 0127, Syracuse, New York
Local Institution - 0214, Tacoma, Washington
Local Institution - 0061, Milwaukee, Wisconsin
Local Institution - 0092, Ciudad autónoma de Buenos Aires, Buenos Aires
Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Buenos Aires
Local Institution - 0091, ABB, Ciudad Autónoma De Buenos Aires
Local Institution - 0106, Buenos Aires, Not set
Local Institution - 0207, Buenos Aires, Not set
Instituto Oncológico de Córdoba, Córdoba, Not set
Local Institution - 0041, Wien, Not set
Hospital Luxemburgo, Belo Horizonte, Minas Gerais
Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa, Porto Alegre, Rio Grande Do Sul
Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul
Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, São Paulo
Hospital Sírio Libanês, Sao Paulo, São Paulo
Hospital Paulistano, Sao Paulo, São Paulo
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo
Hospital São Lucas de Copacabana, Rio de Janeiro, Not set
Centro de Tratamento de Tumores Botafogo para Oncoclinicas Rio de Janeiro SA, Rio de Janeiro, Not set
Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo, Not set
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo, Not set
Local Institution - 0002, Toronto, Ontario
Local Institution - 0123, Trois-Rivières, Quebec
Fundacion Arturo Lopez Perez (FALP), Santiago, Región Metropolitana De Santiago
Oncocentro Apys, Viña del Mar, Valparaíso
Local Institution - 0168, Beijing, Beijing
Local Institution - 0185, Chongqing, Chongqing
Local Institution - 0192, Fuzhou, Fujian
Local Institution - 0169, Xiamen, Fujian
Local Institution - 0180, Guangzhou, Guangdong
Local Institution - 0194, Nanning, Guangxi
Local Institution - 0171, Harbin, Heilongjiang
Local Institution - 0166, Zhengzhou, Henan
Local Institution - 0181, Wuhan Shi, Hubei
Local Institution - 0203, Wuhan, Hubei
Local Institution - 0184, Changsha, Hunan
Local Institution - 0165, Changsha, Hunan
Local Institution - 0193, Nanjing, Jiangsu
Local Institution - 0202, Nanchang, Jiangxi
Local Institution - 0178, Changchun, Jilin
Local Institution - 0183, Xi'an, Shaanxi
Local Institution - 0186, Jinan, Shandong
Local Institution - 0205, Linyi, Shandong
Local Institution - 0164, Shanghai, Shanghai
Local Institution - 0179, Shanghai, Shanghai
Local Institution - 0170, Chengdu, Sichuan
Local Institution - 0177, Chengdu, Sichuan
Local Institution - 0204, Kunming, Yunnan
Local Institution - 0206, Hangzhou, Zhejiang
Local Institution - 0175, Hangzhou, Zhejiang
Nouvel Hôpital Civil (NHC), Strasbourg, Alsace
CHU Bordeaux Haut-Leveque, Pessac, Aquitaine
Centre Georges François Leclerc, Dijon, Côte-d'Or
CHU Charles Nicolle, Rouen, Haute-Normandie
Chu Grenoble Alpes, La Tronche, Isère
Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes, Saint-Herblain, Loire-Atlantique
Centre Hospitalier Lyon Sud, Pierre-Bénite, Rhône
Hopitaux Universitaires Paris Centre-Hopital Cochin, Paris, Not set
Klinikum Esslingen, Esslingen, Baden-Württemberg
Klinikum Würzburg Mitte, Wuerzburg, Bayern
Pius Hospital Oldenburg, Oldenburg, Niedersachsen
Evangelische Lungenklinik Berlin, Berlin, Not set
Local Institution - 0035, Dresden, Not set
Asklepios Klinik Gauting GmbH, Gauting, Not set
Lungenfachklinik Immenhausen, Immenhausen, Not set
Universitaetsklinikum Koeln, Köln, Not set
Marienhaus Klinikum Mainz, Mainz, Not set
University Hospital of Patras, Patras, Achaḯa
Thoracic General Hospital of Athens "I Sotiria", Athens, Attikí
Attikon General University Hospital, Chaidari, Attikí
"Theagenio" Cancer Hospital of Thessaloniki, Thessaloniki, Kentrikí Makedonía
Országos Korányi Pulmonológiai Intézet, Budapest, Not set
All India Institute of Medical Sciences, New Delhi, Delhi
Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, Delhi
Hemato Oncology Clinic, Ahmedabad, Gujarat
HCG Aastha Cancer Centre, Ahmedabad, Gujarat
Local Institution - 0117, Gurgaon, Haryana
Artemis hospital, Gurugram, Haryana
Manipal Hospitals, Bengaluru, Karnataka
Local Institution - 0219, Thiruvananthapuram, Kerala
Local Institution - 0065, Mumbai, Maharashtra
Local Institution - 0048, Mumbai, Maharashtra
Grant Medical Foundation - Ruby Hall Clinic, Pune, Maharashtra
Sahyadri Super Speciality Hospital, Pune, Maharashtra
Local Institution - 0220, Hyderabad, Telangana
Cro-Irccs, Aviano, Friuli-Venezia Giulia
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia
Fondazione IRCCS San Gerardo dei Tintori, Monza, Lombardia
A.O.R.N. Ospedale dei Colli - Monaldi V., Naples, Napoli
Istituto Nazionale Tumori Regina Elena, Rome, Roma
Nagoya University Hospital, Nagoya, Aichi
National Cancer Center Hospital East, Kashiwa, Chiba
National Hospital Organization Shikoku Cancer Center, Matsuyama-shi, Ehime
Hokkaido University Hospital, Sapporo, Hokkaido
Kanagawa cancer center, Yokohama, Kanagawa
Sendai Kosei Hospital, Sendai, Miyagi
Tokyo Metropolitan Komagome Hospital, Bunkyo ku, Tokyo
Tottori University Hospital, Yonago, Tottori
National Hospital Organization Kyushu Cancer Center, Fukuoka, Not set
Osaka City General Hospital, Osaka, Not set
Osaka International Cancer Institute, Osaka, Not set
Tokyo Metropolitan Police Hospital, Tokyo, Not set
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do [Chungbuk]
Seoul National University Bundang Hospital, Seongnam, Kyǒnggi-do
Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul]
Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]
Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0223, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur
Local Institution - 0237, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur
Local Institution - 0222, Lembah Pantai, Wilayah Persekutuan Kuala Lumpur
Local Institution - 0226, Lembah Pantai, Wilayah Persekutuan Kuala Lumpur
Local Institution - 0224, Putrajaya, Wilayah Persekutuan Kuala Lumpur
Amsterdam UMC, locatie VUmc, Amsterdam, Noord-Holland
Local Institution - 0215, Groningen, Not set
Local Institution - 0187, Lublin, Lubelskie
Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie, Olsztyn, Warmińsko-mazurskie
SC Memorial Healthcare International SRL, Bucharest, București
Institutul Oncologic Bucuresti, Bucharest, București
Centrul de Oncologie "Sfântul Nectarie", Craiova, Dolj
Institutul Oncologic Cluj, Cluj, Not set
S.C. Centrul de Oncologie Euroclinic S.R.L., Iași, Not set
CHUAC-Hospital Teresa Herrera, A Coruña, A Coruña [La Coruña]
CHUS - Hospital Clinico Universitario, Santiago de Compostela, A Coruña [La Coruña]
Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]
Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad De
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Comunidad De
H.R.U Málaga - Hospital General, Málaga, Not set
Hospital Universitario Virgen Del Rocio, Sevilla, Not set
Hospital Universitari i Politecnic La Fe, València, Not set
Kantonspital Baden, Baden, Aargau
Ankara Bilkent Şehir Hastanesi, Yenimahalle, Ankara
Adana Medical Park Seyhan Hastanesi, Adana, Not set
Sbü Gülhane Eğitim Ve Araştirma Hastanesi, Ankara, Not set
Medipol Mega Universite Hastanesi, Istanbul, Not set
T.C. Saglik Bakanligi Turkiye Kamu Hastaneleri Kurumu - Bakirkoy Dr. Sadi Konuk Egitim ve Arastirma Hastanesi, Istanbul, Not set
VM Medical Park Pendik Hospital, Istanbul, Not set
Sakarya Training and Research Hospital, Sakarya, Not set
Conditions: Carcinoma, Non-Small-Cell Lung
Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46)
Recruiting
The purpose of this study is to compare pembrolizumab (MK-3475) in combination with sacituzumab govitecan with pembrolizumab alone with respect to progression-free survival (PFS) and overall survival (OS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as assessed by blinded independent central review (BICR) among adults with metastatic non-small cell lung cancer (NSCLC) with programmed cell death ligand 1 (PD-L1) tumor proportion score (TPS) ≥50%).
The purpose of this study is to compare pembrolizumab (MK-3475) in combination with sacituzumab govitecan with pembrolizumab alone with respect to progression-free survival (PFS) and overall survival (OS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as assessed by blinded independent central review (BICR) among adults with metastatic non-small cell lung cancer (NSCLC) with programmed cell death ligand 1 (PD-L1) tumor proportion score (TPS) ≥50%). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/24/2025
Locations: Infirmary Cancer Care ( Site 0418), Mobile, Alabama +177 locations
Infirmary Cancer Care ( Site 0418), Mobile, Alabama
Clermont Oncology Center ( Site 0421), Clermont, Florida
University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 0417), Miami, Florida
Mid Florida Hematology and Oncology Center ( Site 0416), Orange City, Florida
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0407), Marietta, Georgia
Our Lady of the Lake RMC ( Site 0424), Baton Rouge, Louisiana
Henry Ford Hospital ( Site 0412), Detroit, Michigan
Profound Research LLC ( Site 0440), Farmington Hills, Michigan
Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0425), Minneapolis, Minnesota
Basil Clinical ( Site 0441), Inwood, New York
White Plains Hospital-Center for Cancer Care ( Site 0403), White Plains, New York
Kaiser Permanente Northwest-Central Interstate--Oncology ( Site 0408), Portland, Oregon
Oregon Health & Science University ( Site 0427), Portland, Oregon
Houston Methodist Hospital ( Site 0419), Houston, Texas
Central Texas Veterans health care ( Site 0414), Temple, Texas
Orange Hospital-Clinical Trials Unit ( Site 0600), Orange, New South Wales
Cancer Research SA-St Andrews Hospital ( Site 0603), Adelaide, South Australia
Frankston Hospital-Oncology and Haematology ( Site 0601), Frankston, Victoria
CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA ( Site 0320), Fortaleza, Ceara
Hospital Tacchini ( Site 0322), Bento Goncalves, Rio Grande Do Sul
Hospital da Cidade de Passo Fundo ( Site 0321), Passo Fundo, Rio Grande Do Sul
Instituto de Oncologia Saint Gallen ( Site 0317), Santa Cruz do Sul, Rio Grande Do Sul
Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0318), Barretos, Sao Paulo
A. C. Camargo Cancer Center ( Site 0324), Sao Paulo, Not set
BC Cancer Abbotsford-Medical Oncology ( Site 0433), Abbotsford, British Columbia
Southlake Regional Health Centre-Oncology Clinical Trials ( Site 0435), Newmarket, Ontario
Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre ( Site 0430), Greenfield Park, Quebec
St. Marys Hospital Center-Oncology ( Site 0434), Montreal, Quebec
Centre integre universitaire de sante et de services sociaux-oncology ( Site 0431), Trois-Rivières, Quebec
Oncovida ( Site 0334), Santiago., Region M. De Santiago
Pontificia Universidad Catolica de Chile ( Site 0332), Santiago, Region M. De Santiago
Second Affiliated hospital of Anhui Medical University ( Site 0126), Hefei, Anhui
Anhui Provincial Hospital ( Site 0136), Hefei, Anhui
Beijing Cancer hospital ( Site 0104), Beijing, Beijing
Beijing Peking Union Medical College Hospital-pneumology department ( Site 0106), Beijing, Beijing
Beijing Chest Hospital,Capital Medical University ( Site 0105), Beijing, Beijing
Chongqing University Cancer Hospital-Medical Oncology ( Site 0130), Chongqing, Chongqing
Fujian Provincial Cancer Hospital ( Site 0131), Fuzhou, Fujian
The First Affiliated hospital of Xiamen University ( Site 0132), Xiamen, Fujian
Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine ( Site 0125), Guangzhou, Guangdong
Affiliated Cancer Hospital of Guangxi Medical University ( Site 0113), Nanning, Guangxi
Harbin Medical University Cancer Hospital ( Site 0119), Harbin, Heilongjiang
Henan Cancer Hospital ( Site 0127), Zhengzhou, Henan
Tongji Hospital Tongji Medical,Science & Technology ( Site 0116), Wuhan, Hubei
Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 0115), Wuhan, Hubei
Hubei Cancer Hospital ( Site 0107), Wuhan, Hubei
Xiangya Hospital Central South University ( Site 0124), Changsha, Hunan
The Second Xiangya Hospital of Central South University ( Site 0135), Changsha, Hunan
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School ( Site 0112), Nanjing, Jiangsu
Nantong Tumor Hospital-Medical Oncology ( Site 0122), Nantong, Jiangsu
The First Affliated Hospital of Suzhou University ( Site 0114), Suzhou, Jiangsu
The Second Affiliated Hospital of Nanchang University ( Site 0134), Nanchang, Jiangxi
The First Hospital of Jilin University ( Site 0117), Changchun, Jilin
Jilin Province Tumor Hospital-clinical research ( Site 0118), Changchun, Jilin
The First Affiliated Hospital of Xi'an Jiaotong University-Oncology ( Site 0133), Xi'an, Shaanxi
Jinan Central Hospital-oncology department ( Site 0121), Jinan, Shandong
LinYi Cancer Hospital ( Site 0120), Linyi, Shandong
Shanghai Chest Hospital ( Site 0101), Shanghai, Shanghai
Fudan University Shanghai Cancer Center-Oncology ( Site 0102), Shanghai, Shanghai
Huashan Hospital, Fudan University ( Site 0103), Shanghai, Shanghai
West China Hospital of Sichuan University ( Site 0129), Cheng Du, Sichuan
Sichuan Cancer hospital. ( Site 0128), Chengdu, Sichuan
The First Affiliated Hospital, Zhejiang University ( Site 0109), Hangzhou, Zhejiang
The Second Affiliated hospital of Zhejiang University school of medicine ( Site 0110), Hangzhou, Zhejiang
Sir Run Run Shaw Hospital-Medical Oncology ( Site 0111), Hangzhou, Zhejiang
Zhejiang Cancer Hospital ( Site 0108), Hangzhou, Zhejiang
North Estonia Medical Centre Foundation-Chemotherapy ( Site 0621), Tallinn, Harjumaa
Tartu University Hospital-Radiotherapy and oncology ( Site 0620), Tartu, Tartumaa
Universitätsmedizin Mannheim ( Site 0654), Mannheim, Baden-Wurttemberg
Klinikum Kempten ( Site 0655), Kempten, Bayern
Klinikum Würzburg Mitte ( Site 0651), Wuerzburg, Bayern
Katholisches Klinikum Koblenz ( Site 0650), Koblenz, Rheinland-Pfalz
Krankenhaus Martha-Maria Halle-Dölau-Klinik für Innere Medizin II ( Site 0657), Halle, Sachsen-Anhalt
Vivantes Hospital Spandau-Klinik für Innere Medizin, Hämatologie, Onkologie und Gastroenterologie- ( Site 0656), Berlin, Not set
Helios Klinikum Emil von Behring Berlin-Zehlendorf-Lungenklinik Heckeshorn ( Site 0653), Berlin, Not set
Errikos Dunant Hospital Center-Fourth Department of Oncology and Clinical Trials Unit ( Site 0141), Athens, Attiki
Sotiria Thoracic Diseases Hospital of Athens-3rd Dept of Internal Medicine, Oncology Unit ( Site 0140), Athens, Attiki
European Interbalkan Medical Center-Oncology Department ( Site 0142), Thessaloniki, Not set
Shaare Zedek Medical Center-Oncology ( Site 0176), Jerusalem, Not set
Meir Medical Center-oncology ( Site 0171), KfarSaba, Not set
Rabin Medical Center-Oncology ( Site 0174), Petah Tikva, Not set
Sourasky Medical Center-Oncology ( Site 0175), Tel Aviv, Not set
Yitzhak Shamir Medical Center. ( Site 0179), Zerifin, Not set
Azienda Ospedaliera S. Giovanni Addolorata-Oncologia Medica ( Site 0677), Roma, Lazio
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII ( Site 0674), Bergamo, Lombardia
Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 0673), Milan, Lombardia
Azienda Ospedaliera Dei Colli-U.O.C Pneumologia Oncologica DH PNL ONC ( Site 0671), Naples, Napoli
Azienda Ospedaliera Universitaria Careggi-SOD ONCOLOGIA MEDICA ( Site 0675), Firenze, Toscana
Casa di Cura Dott. Pederzoli-LUNG-UNIT TORACIC ( Site 0670), Peschiera del Garda, Verona
Azienda Ospedaliero Universitaria di Parma-UO Oncologia Medica ( Site 0676), Parma, Not set
Aichi Cancer Center ( Site 0018), Nagoya, Aichi
National Hospital Organization Shikoku Cancer Center ( Site 0008), Matsuyama, Ehime
Kurume University Hospital ( Site 0014), Kurume, Fukuoka
Takarazuka City Hospital ( Site 0015), Takarazuka, Hyogo
Kanazawa University Hospital ( Site 0019), Kanazawa, Ishikawa
Kanagawa Cancer Center ( Site 0016), Yokohama, Kanagawa
Miyagi Cancer Center ( Site 0001), Natori, Miyagi
Sendai Kousei Hospital ( Site 0012), Sendai, Miyagi
Niigata Cancer Center Hospital ( Site 0017), Niigata-shi, Niigata
Kurashiki Central Hospital ( Site 0011), Kurashiki, Okayama
Kansai Medical University Hospital ( Site 0005), Hirakata, Osaka
Kindai University Hospital ( Site 0013), Sayama, Osaka
Saitama Prefectural Cancer Center ( Site 0002), Kitaadachi-gun, Saitama
Shizuoka Cancer Center ( Site 0004), Nagaizumi-cho,Sunto-gun, Shizuoka
Tokyo Metropolitan Komagome Hospital ( Site 0020), Bunkyo ku, Tokyo
National Hospital Organization Kyushu Medical Center ( Site 0009), Fukuoka, Not set
Kyushu University Hospital ( Site 0010), Fukuoka, Not set
Okayama University Hospital ( Site 0007), Okayama, Not set
Nippon Medical School Hospital ( Site 0003), Tokyo, Not set
Wakayama Medical University Hospital ( Site 0006), Wakayama, Not set
Chonnam National University Hwasun Hospital-Pulmonology ( Site 0061), Hwasun, Jeonranamdo
Pusan National University Yangsan Hospital ( Site 0060), Pusan, Kyongsangnam-do
Chungnam national university hospital-Department of Internal Medicine ( Site 0063), Daejeon, Taejon-Kwangyokshi
Asan Medical Center ( Site 0064), Seoul, Not set
Korea University Guro Hospital-Internal Medicine ( Site 0062), Seoul, Not set
Daugavpils Regional Hospital-Oncology Department ( Site 0194), Daugavpils, Daugavpils Novads
Liepjas reionl slimnca ( Site 0191), Liepaja, Not set
Pauls Stradins Clinical Univeristy Hospital-Chemotherapy department ( Site 0192), Riga, Not set
RIGA EAST UNIVERSITY HOSPITAL ,Oncology Centre of Latvia-Out-patient and Day patient facility of Ch ( Site 0193), Riga, Not set
Hospital of Lithuanian University of Health Sciences Kauno klinikos-Pulmonology ( Site 0692), Kaunas, Kauno Apskritis
National Cancer Institute-Department of Thoracic Surgery and Oncology ( Site 0691), Vilnius, Vilniaus Miestas
Hospital Raja Perempuan Zainab II-Medical Department ( Site 0035), Kota Bharu, Kelantan
Hospital Pulau Pinang-Oncology, radiotherapy and palliat ( Site 0034), George Town, Pulau Pinang
Beacon Hospital Sdn Bhd ( Site 0033), Petaling Jaya, Selangor
COI Tijuana - Centro Oncológico Internacional ( Site 0350), Tijuana, Baja California
Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Servicio de Oncología ( Site 0352), Monterrey, Nuevo Leon
Medical Care and Research SA de CV ( Site 0353), Merida, Yucatan
Centro de Investigacion Medica Aguascalientes ( Site 0340), Aguascalientes, Not set
Oaxaca Site Management Organization ( Site 0346), Oaxaca, Not set
Centro de Investigacion Clinica de Oaxaca ( Site 0351), Oaxaca, Not set
Clinica Vallesur - AUNA ( Site 0360), Arequipa, Ariqipa
Instituto Regional de Enfermedades Neoplasicas del Centro (IREN CENTRO) ( Site 0362), Concepcion, Junin
Centro de investigacion Clínica Trujillo ( Site 0358), Trujillo, La Libertad
Detecta Clínica ( Site 0364), Surquillo, Lima
Clínica Internacional - Sede San Borja ( Site 0356), Lima, Not set
Instituto Neuro Cardiovascular de las Americas ( Site 0365), Lima, Not set
Hospital Cayetano Heredia ( Site 0361), Lima, Not set
Metro Davao Medical and Research Center ( Site 0047), Davao City, Davao Del Sur
ST. LUKE'S MEDICAL CENTER ( Site 0046), Quezon City, National Capital Region
Cebu Doctors University Hospital ( Site 0045), Cebu, Not set
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 0208), Bydgoszcz, Kujawsko-pomorskie
Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 0201), Siedlce, Mazowieckie
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 0200), Warszawa, Mazowieckie
Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 0203), Przemysl, Podkarpackie
Szpital Specjalistyczny w Prabutach Spolka z o.o. ( Site 0202), Prabuty, Pomorskie
Szpital Rejonowy im. dr. J. Rostka w Raciborzu ( Site 0207), Racibórz, Slaskie
Med-Polonia Sp. z o. o. ( Site 0204), Poznan, Wielkopolskie
Gral Medical SRL-Medical Oncology ( Site 0220), București, Bucuresti
Cardiomed SRL Cluj-Napoca ( Site 0217), Cluj-Napoca, Cluj
Amethyst Radiotherapy Center-Oncologie Medicala ( Site 0216), Florești, Cluj
Centrul de Oncologie Sfantul Nectarie-Medical ( Site 0215), Craiova, Dolj
Cabinet Medical Oncomed ( Site 0219), Timisoara, Timis
Institutul Oncologic-Oncologie Medicala ( Site 0218), Cluj, Not set
Chung Shan Medical University Hospital ( Site 0078), Taichung City, Taichung
National Taiwan University Cancer Center (NTUCC) ( Site 0079), Taipei City, Taipei
E-Da hospital ( Site 0075), Kaohsiung, Not set
China Medical University Hospital-Internal Medicine ( Site 0083), Taichung, Not set
National Cheng Kung University Hospital-Clinical Trial Center ( Site 0076), Tainan, Not set
National Taiwan University Hospital-Internal Medicine ( Site 0080), Taipei, Not set
Chang Gung Medical Foundation-Linkou Branch ( Site 0082), Taoyuan, Not set
Maharaj Nakorn Chiang Mai Hospital ( Site 0092), Muang, Chiang Mai
Bangkok Metropolitan Administration Medical College and Vajira Hospital ( Site 0097), Bangkok, Krung Thep Maha Nakhon
Faculty of Medicine Siriraj Hospital ( Site 0090), Bangkok, Krung Thep Maha Nakhon
Lampang Cancer Hospital ( Site 0098), Mueang Lampang, Lampang
Songklanagarind hospital ( Site 0091), HatYai, Songkhla
Sunpasitthiprasong Hospital ( Site 0093), Ubon Ratchathani, Not set
Hacettepe Universite Hastaneleri-oncology hospital ( Site 0265), Ankara, Not set
Liv Hospital Ankara-Oncology ( Site 0274), Ankara, Not set
Ankara City Hospital-Medical Oncology ( Site 0268), Ankara, Not set
Trakya University-Medical Oncology ( Site 0270), Edirne, Not set
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 0267), Istanbul, Not set
VM Medical Park Pendik Hospital ( Site 0271), Istanbul, Not set
I.E.U. Medical Point Hastanesi-Oncology ( Site 0266), Izmir, Not set
Mersin Sehir Eğitim ve Araştırma Hastanesi ( Site 0275), Mersin, Not set
Leicester Royal Infirmary-HOPE Clinical Trials Unit ( Site 0300), Leicester, Leicestershire
St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 0302), London, London, City Of
University College London Hospital ( Site 0305), London, London, City Of
The Clatterbridge Cancer Centre ( Site 0303), Wirral, Not set
Conditions: Carcinoma, Non-Small-Cell Lung
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Recruiting
The goal of this clinical trial is to determine clinical advantages for LP-300 in combination with carboplatin and pemetrexed in the never smoker patient population. The primary objectives of this study are to determine progression-free survival (PFS) and overall survival (OS) in the study-defined patient population when LP-300 is co-administered with the standard of care chemotherapy drugs carboplatin and pemetrexed compared to carboplatin and pemetrexed alone. This has been designed as a multi... Read More
The goal of this clinical trial is to determine clinical advantages for LP-300 in combination with carboplatin and pemetrexed in the never smoker patient population. The primary objectives of this study are to determine progression-free survival (PFS) and overall survival (OS) in the study-defined patient population when LP-300 is co-administered with the standard of care chemotherapy drugs carboplatin and pemetrexed compared to carboplatin and pemetrexed alone. This has been designed as a multicenter, open label, phase II trial with 90 patients to be enrolled in the United States. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/24/2025
Locations: Precision NextGen Oncology and Research Center, Beverly Hills, California +15 locations
Precision NextGen Oncology and Research Center, Beverly Hills, California
Los Angeles Cancer Network, Fountain Valley, California
Cancer and Blood Specialists Clinic, Los Alamitos, California
Fox Chase Cancer Center, Philadelphia, Pennsylvania
UT Southwestern Medical Center, Dallas, Texas
Inova Fairfax Hospital, Fairfax, Virginia
Hokkaido Cancer Center, Sapporo-Shi, Hokkaido
Kanagawa Cancer Center Hospital, Yokohama-Shi, Kanagawa
Tohoku University Hospital, Sendai-shi, Miyagi
Okayama University Hospital, Okayama-shi, Okayama
National Cancer Center Hospital, Chuo-ku, Tokyo
National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Not set
Chi Mei Medical Center, Tainan, Not set
National Cheng Kung University Hospital, Tainan, Not set
Taipei Veterans General Hospital, Taipei, Not set
TriService General Hospital-Neihu Main Facility, Taipei, Not set
Conditions: Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Recruiting
This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo plus pembrolizumab plus platinum-doublet chemotherapy in participants with previously untreated, locally advanced or metastatic NSCLC with KRAS G12C mutation
This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo plus pembrolizumab plus platinum-doublet chemotherapy in participants with previously untreated, locally advanced or metastatic NSCLC with KRAS G12C mutation Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/23/2025
Locations: Local Institution - 0347, Birmingham, Alabama +327 locations
Local Institution - 0347, Birmingham, Alabama
Local Institution - 0581, Fullerton, California
Local Institution - 0202, Long Beach, California
Local Institution - 0643, Newport Beach, California
Local Institution - 0666, Orange, California
Local Institution - 0623, Santa Barbara, California
Local Institution - 0442, Denver, Colorado
Local Institution - 0651, Gainesville, Florida
Local Institution - 0621, Palm Bay, Florida
Local Institution - 0377, Tamarac, Florida
Local Institution - 0647, Tampa, Florida
Local Institution - 0392, Fort Eisenhower, Georgia
Local Institution - 0031, Marietta, Georgia
Local Institution - 0665, Arlington Heights, Illinois
Local Institution - 0423, Munster, Indiana
Local Institution - 0366, Edgewood, Kentucky
Local Institution - 0566, Louisville, Kentucky
Local Institution - 0644, Shreveport, Louisiana
Local Institution - 0385, Columbia, Maryland
Local Institution - 0019, Boston, Massachusetts
Local Institution - 0437, Worcester, Massachusetts
Local Institution - 0618, White Plains, New York
Local Institution - 0624, Asheville, North Carolina
Local Institution - 0672, Salisbury, North Carolina
Local Institution - 0620, Columbus, Ohio
Local Institution - 0657, York, Pennsylvania
Local Institution - 0658, Greenville, South Carolina
Local Institution - 0652, Laredo, Texas
Local Institution - 0622, San Antonio, Texas
Local Institution - 0575, Ciudad Autónoma de Buenos Aires, Buenos Aires
IDIM - Instituto de Investigaciones Metabólicas, Ciudad de Buenos Aires, Buenos Aires
Local Institution - 0584, Pilar, Buenos Aires
Hospital Italiano de Buenos Aires, ABB, Ciudad Autónoma De Buenos Aires
Local Institution - 0571, Buenos Aires, Ciudad Autónoma De Buenos Aires
Clinica Adventista Belgrano, Caba, Ciudad Autónoma De Buenos Aires
Sanatorio Plaza, Rosario, Santa Fe
Local Institution - 0126, Canberra, Australian Capital Territory
Tamworth Hospital, North Tamworth, New South Wales
Orange Hospital, Orange, New South Wales
Princess Alexandra Hospital, Brisbane, Queensland
Lyell McEwin Hospital, Elizabeth Vale, South Australia
Frankston Hospital, Frankston, Victoria
Northern Hospital, Melbourne, Victoria
Local Institution - 0160, Traralgon, Victoria
Joondalup Health Campus, Joondalup, Western Australia
Klinikum Wels-Grieskirchen GmbH, Wels, Oberösterreich
Medizinische Universität Graz, Graz, Steiermark
Kepler Universitätsklinikum, Linz, Not set
Medizinische Universität Wien, Wien, Not set
Local Institution - 0673, Wien, Not set
UZ Brussel, Brussels, Bruxelles-Capitale, Région De
Cliniques universitaires Saint-Luc, Brussels, Bruxelles-Capitale, Région De
Local Institution - 0215, Hasselt, Limburg
Local Institution - 0216, Gent, Oost-Vlaanderen
UZ Leuven, Leuven, Vlaams-Brabant
Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman, Liège, Not set
Local Institution - 0257, Salvador, Bahia
Local Institution - 0242, Vitória, Espírito Santo
Local Institution - 0244, Belo Horizonte, Minas Gerais
Local Institution - 0235, Ijui, Rio Grande Do Sul
Local Institution - 0233, Porto Alegre, Rio Grande Do Sul
Local Institution - 0238, Santa Cruz do Sul, Rio Grande Do Sul
Local Institution - 0243, Porto Velho, Rondonia
Local Institution - 0237, Blumenau, Santa Catarina
Local Institution - 0245, Itajaí, Santa Catarina
Local Institution - 0240, Barretos, São Paulo
Local Institution - 0254, Sao Paulo, São Paulo
Local Institution - 0241, São Carlos, São Paulo
Local Institution - 0239, São José do Rio Preto, São Paulo
Local Institution - 0236, Rio de Janeiro, Not set
Local Institution - 0258, São Paulo, Not set
Local Institution - 0629, Panagyurishte, Pazardzhik
Local Institution - 0628, Sofia, Sofia (stolitsa)
Complex Oncology Center - Ruse EOOD, Ruse, Not set
Local Institution - 0635, Stara Zagora, Not set
Local Institution - 0074, Halifax, Nova Scotia
Local Institution - 0559, Montreal, Quebec
Bradfordhill, Recoleta, Región Metropolitana De Santiago
FALP, Santiago, Región Metropolitana De Santiago
The First Afflilated Hospital of Bengbu Medical College, Bengbu, Anhui
Anhui Provincial Hospital, Hefei, Anhui
Beijing Cancer hospital, Beijing, Beijing
Local Institution - 0491, Beijing, Beijing
Local Institution - 0397, Beijing, Beijing
Chongqing University Cancer Hospital, Chongqing, Chongqing
Local Institution - 0362, Fuzhou Fujian, Fujian
Local Institution - 0383, Xiamen, Fujian
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong
Local Institution - 0625, Guangzhou, Guangdong
Cancer Hospital of Shantou University Medical College, Shantou, Guangdong
Local Institution - 0461, Shenzhen, Guangdong
ShenZhen People's Hospital, Shenzhen, Guangdong
Local Institution - 0464, Nanning, Guangxi
Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
Nanyang City Center Hospital, Nanyang, Henan
Local Institution - 0494, Xinxiang, Henan
Tongji Hospital Tongji Medical,Science & Technology, Wuhan, Hubei
Local Institution - 0398, Changsha, Hunan
Local Institution - 0371, Nanjing, Jiangsu
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu
Local Institution - 0378, Yangzhou, Jiangsu
Local Institution - 0467, Nanchang, Jiangxi
The First Hospital of Jilin University, Changchun, Jilin
Local Institution - 0473, Shenyang, Liaoning
Local Institution - 0479, Shenyang, Liaoning
Local Institution - 0493, Shenyang, Liaoning
Shandong Cancer Hospital, Jinan, Shandong
LinYi Cancer Hospital, Linyi, Shandong
Local Institution - 0470, Shanghai, Shanghai
Local Institution - 0381, Shanghai, Shanghai
Local Institution - 0353, Taiyuan, Shanxi
Local Institution - 0384, Cheng Du, Sichuan
Local Institution - 0667, Chengdu, Sichuan
Tianjin Medical University General Hospital, Tianjin, Tianjin
Local Institution - 0462, Hangzhou, Zhejiang
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang
Local Institution - 0463, Hangzhou, Zhejiang
Taizhou Hospital of Zhejiang Province, Linhai, Zhejiang
Shanghai East Hospital, Shanghai, Not set
Local Institution - 0580, Medellín, Antioquia
Local Institution - 0171, Rionegro, Antioquia
Local Institution - 0191, Puerto Colombia, Atlántico
Local Institution - 0253, Valledupar, Cesar
Local Institution - 0167, Montería, COR
Local Institution - 0671, Bogota, Cundinamarca
Local Institution - 0189, Bogotá, Distrito Capital De Bogotá
Local Institution - 0170, Floridablanca, Santander
Local Institution - 0173, Cali, Valle Del Cauca
Local Institution - 0619, Dubrovnik, Dubrovačko-neretvanska Županija
Local Institution - 0664, Rijeka, Primorsko-goranska Županija
Local Institution - 0639, Split, Splitsko-dalmatinska Županija
Local Institution - 0567, Osijek, Not set
Local Institution - 0585, Zagreb, Not set
Local Institution - 0159, Mulhouse, Alsace
Centre François Baclesse, Caen, Calvados
Centre Georges François Leclerc, Dijon, Côte-d'Or
CHRU de Brest, Brest, Finistère
Institut Régional du Cancer Montpellier, Montpellier, Hérault
Chu Grenoble Alpes, La Tronche, Isère
Local Institution - 0560, Angers, Maine-et-Loire
Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois, Vandoeuvre lès Nancy, Meurthe-et-Moselle
Local Institution - 0636, Marseille, Provence-Alpes-Côte-d'Azur
Local Institution - 0552, Amiens, Somme
Gustave Roussy, Villejuif, Val-de-Marne
Hôpital Ambroise Paré, Boulogne-Billancourt, Not set
Chu Gabriel Montpied, Clermont-Ferrand, Not set
Local Institution - 0604, Limoges, Not set
Local Institution - 0164, Marseille, Not set
Local Institution - 0133, Paris, Not set
Hopitaux Universitaires Paris Centre-Hopital Cochin, Paris, Not set
Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes, Saint-Herblain, Not set
Klinikum Esslingen, Esslingen, Baden-Württemberg
Local Institution - 0670, Ulm, Baden-Württemberg
Klinikum der Ludwig-Maximilians-Universitaet Muenchen, München, Bayern
Centrum für Hämatologie und Onkologie Bethanien, Frankfurt, Hessen
Local Institution - 0535, Gießen, Hessen
Praxis Onkologie am Raschplatz, Hannover, Niedersachsen
Pius Hospital Oldenburg, Oldenburg, Niedersachsen
Local Institution - 0603, Herne, Nordrhein-Westfalen
Klinikum Köln-Merheim, Köln, Nordrhein-Westfalen
Local Institution - 0522, Halle, Sachsen-Anhalt
Malteser Krankenhaus St. Franziskus-Hospital, Flensburg, Schleswig-Holstein
Local Institution - 0524, Gera, Thüringen
Universitätsklinikum Jena, Jena, Thüringen
Vivantes Klinikum Neukölln, Berlin, Not set
Local Institution - 0537, Berlin, Not set
Local Institution - 0675, Halle, Not set
Local Institution - 0528, Hemer, Not set
Local Institution - 0517, Stuttgart, Not set
Local Institution - 0525, Wuerzburg, Not set
Local Institution - 0608, Athens, Attikí
Local Institution - 0612, Athens, Attikí
Local Institution - 0609, Larissa, Thessalía
Queen Mary Hospital, Hksar, Not set
Queen Mary Hospital, Hksar, Not set
Local Institution - 0601, Gyor, Győr-Moson-Sopron
Local Institution - 0144, Gyöngyös, Heves
Local Institution - 0157, Tatabánya, Komárom-Esztergom
Local Institution - 0593, Kaposvár, Somogy
Local Institution - 0143, Farkasgyepu, Veszprém
Local Institution - 0151, Budapest, Not set
Local Institution - 0140, Budapest, Not set
Local Institution - 0222, Visakhapatnam, Andhra Pradesh
Local Institution - 0312, New Delhi, Delhi
Local Institution - 0511, New Delhi, Delhi
Local Institution - 0135, New Delhi, Delhi
Local Institution - 0136, Ahmedabad, Gujarat
Local Institution - 0230, Ahmedabad, Gujarat
Local Institution - 0155, Thiruvananthapuram, Kerala
Local Institution - 0154, Mumbai, Maharashtra
Local Institution - 0226, Bhubaneswar, Odisha
Local Institution - 0224, Madurai, Tamil Nadu
Local Institution - 0663, Hyderabad, Telangana
Local Institution - 0153, Varanasi, Uttar Pradesh
Local Institution - 0161, Howrah, West Bengal
Local Institution - 0221, Kolkata, West Bengal
Local Institution - 0661, Hyderabad, Not set
Local Institution - 0102, Cork, Not set
Mater Private Hospital - Dublin, Dublin, Not set
Local Institution - 0101, Dublin, Not set
Local Institution - 0100, Dublin, Not set
Local Institution - 0106, Dublin, Not set
Local Institution - 0597, Petah Tikva, HaMerkaz
Local Institution - 0596, Ramat Gan, HaMerkaz
Yitzhak Shamir Medical Center, Zerifin, HaMerkaz
Hadassah Medical Center, Jerusalem, Yerushalayim
Local Institution - 0613, Haifa, Ḥeifā
IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Emilia-Romagna
Local Institution - 0066, Naples, Napoli
Local Institution - 0070, Orbassano, Piemonte
Local Institution - 0071, Bari, Puglia
Local Institution - 0068, Rome, Roma
Local Institution - 0069, Firenze, Toscana
Local Institution - 0588, Genova, Not set
Local Institution - 0073, Padova, Not set
Local Institution - 0156, Parma, Not set
Local Institution - 0543, Pavia, Not set
Local Institution - 0556, Varese, Not set
Local Institution - 0607, Nagoya, Aichi
Local Institution - 0305, Nagoya, Aichi
Local Institution - 0298, Sapporo, Hokkaido
Local Institution - 0304, Kanazawa, Ishikawa
Local Institution - 0302, Sagamihara, Kanagawa
Local Institution - 0369, Yokohama, Kanagawa
Local Institution - 0301, Sendai, Miyagi
Local Institution - 0306, Kashihara, Nara
Local Institution - 0368, Kurashiki, Okayama
Local Institution - 0642, Hirakata, Osaka
Local Institution - 0303, Hidaka, Saitama
Local Institution - 0300, Ina-machi, Saitama
Local Institution - 0606, Hamamatsu, Shizuoka
Local Institution - 0299, Shimotsuga, Tochigi
Local Institution - 0343, Toyoma, Toyama
Local Institution - 0542, Iwakuni, Yamaguchi
Local Institution - 0307, Akashi, Not set
Local Institution - 0346, Aomori, Not set
Local Institution - 0310, Fukuoka, Not set
Local Institution - 0367, Fukushima, Not set
Local Institution - 0308, Kumamoto, Not set
Local Institution - 0297, Osaka, Not set
Local Institution - 0309, Osaka, Not set
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do [Chungbuk]
Gachon University Gil Medical Center, Namdong-gu, Incheon-gwangyeoksi [Incheon]
Pusan National University Yangsan Hospital, Yangsan, Kyǒngsangnam-do
Pusan National University Hospital, Busan, Pusan-Kwangyǒkshi
Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul]
Konkuk University Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]
The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul]
Korea University Guro Hospital, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0583, Saltillo, Coahuila
Local Institution - 0176, Mexico City, DIF
Local Institution - 0579, Pachuca, Hidalgo
Local Institution - 0178, Guadalajara, Jalisco
Local Institution - 0591, Monterrey, Nuevo León
Local Institution - 0175, Chihuahua, Not set
Local Institution - 0181, Puebla, Not set
Local Institution - 0638, Puebla, Not set
Local Institution - 0180, Veracruz, Not set
Local Institution - 0615, Maastricht, Limburg
Local Institution - 0594, Amsterdam, Noord-Holland
Local Institution - 0205, Wrocław, Dolnośląskie
Local Institution - 0080, Lublin, Lubelskie
Local Institution - 0206, Gorlice, Małopolskie
Local Institution - 0079, Kraków, Małopolskie
Med-Polonia Sp. z o. o., Poznan, Wielkopolskie
Centrum Onkologii im. Prof. Franciszka Lukaszczyka, Bydgoszcz, Not set
Local Institution - 0078, Katowice, Not set
Szpital Specjalistyczny w Prabutach Spolka z o.o., Prabuty, Not set
Local Institution - 0509, Lisbon, Lisboa
Local Institution - 0510, Coimbra, Not set
Local Institution - 0553, Porto, Not set
SC Memorial Healthcare International SRL, Bucharest, București
Institutul Oncologic Bucuresti, Bucharest, București
Local Institution - 0276, Cluj-Napoca, Cluj
SC Radiotherapy Center Cluj SRL, Florești, Cluj
Ovidius Clinical Hospital OCH, Ovidiu, Constanța
Centrul de Oncologie "Sfântul Nectarie", Craiova, Dolj
Spitalul Municipal Schuller Ploiești, Ploiești, Prahova
Cabinet Medical Oncomed, Timișoara, Timiș
Institutul Oncologic Cluj, Cluj, Not set
Local Institution - 0270, Cluj, Not set
Affidea Constanța, Constanța, Not set
S.C. Centrul de Oncologie Euroclinic S.R.L., Iași, Not set
Institutul Regional de Oncologie, Iași, Not set
Local Institution - 0614, Jeddah, Makkah Al Mukarramah
Local Institution - 0602, Riyadh, Not set
Local Institution - 0562, Riyadh, Not set
Local Institution - 0499, A Coruña, A Coruña [La Coruña]
Local Institution - 0506, Santiago de Compostela, A Coruña [La Coruña]
Local Institution - 0501, Barcelona, Barcelona [Barcelona]
Local Institution - 0497, Hospitalet, Barcelona [Barcelona]
Local Institution - 0505, Barcelona, Catalunya [Cataluña]
Hospital Son Llàtzer, Palma, Illes Balears [Islas Baleares]
Local Institution - 0500, Madrid, Madrid, Comunidad De
Hospital Universitario Ramón y Cajal, Madrid, Madrid, Comunidad De
Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad De
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Comunidad De
Local Institution - 0669, Pontevedra, Pontevedra [Pontevedra]
Hospital Arnau de Vilanova, Valencia, València
Hospital Clinico San Carlos, Madrid, Not set
H.R.U Málaga - Hospital General, Málaga, Not set
Hospital Universitario Virgen Del Rocio, Sevilla, Not set
Local Institution - 0495, València, Not set
Kantonsspital Münsterlingen - Spital Thurgau AG, Münsterlingen, Not set
Chi Mei Hospital - Liouying Branch, Tainan City, Tainan
Tri-Service General Hospital, Taipei City, Taipei
Taipei Medical University Shuang Ho Hospital, New Taipei, Not set
National Cheng Kung University Hospital, Tainan, Not set
National Taiwan University Hospital, Taipei, Not set
Local Institution - 0565, Muang, Khon Kaen
Local Institution - 0563, Bangkok, Krung Thep Maha Nakhon
Local Institution - 0564, Hatyai, Songkhla
Local Institution - 0548, Stanbul, İstanbul
Local Institution - 0199, Izmir, Karsiyaka, İzmir
Local Institution - 0197, Adana, Not set
Local Institution - 0201, Ankara, Not set
Local Institution - 0194, Ankara, Not set
Local Institution - 0198, Ankara, Not set
Local Institution - 0550, Istanbul, Not set
Local Institution - 0549, Istanbul, Not set
Local Institution - 0200, Izmir, Not set
University College London Hospital, London, London, City Of
Guy's & St Thomas' NHS Foundation Trust, London, London, City Of
Local Institution - 0092, Birmingham, Not set
Local Institution - 0090, Guildford, Not set
Local Institution - 0545, Guildford, Not set
Local Institution - 0093, Manchester, Not set
Conditions: Carcinoma, Non-Small-Cell Lung
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Recruiting
The main purpose of this study is to assess if olomorasib in combination with pembrolizumab is more effective than the pembrolizumab and placebo combination in part A in participants with resected KRAS G12C-mutant NSCLC and to assess if olomorasib in combination with durvalumab is more effective than the durvalumab and placebo combination in part B in participants with unresectable KRAS G12C-mutant non-small cell lung cancer. The study may last up to 3 years for each participant.
The main purpose of this study is to assess if olomorasib in combination with pembrolizumab is more effective than the pembrolizumab and placebo combination in part A in participants with resected KRAS G12C-mutant NSCLC and to assess if olomorasib in combination with durvalumab is more effective than the durvalumab and placebo combination in part B in participants with unresectable KRAS G12C-mutant non-small cell lung cancer. The study may last up to 3 years for each participant. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/22/2025
Locations: University of Alabama at Birmingham, Birmingham, Alabama +347 locations
University of Alabama at Birmingham, Birmingham, Alabama
Clearview Cancer Institute, Huntsville, Alabama
The University of Arizona Cancer Center - North Campus, Tucson, Arizona
Highlands Oncology Group, Springdale, Arkansas
UCLA Hematology/Oncology - Santa Monica, Los Angeles, California
Profound Research LLC, Oceanside, California
University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange, California
Stanford Cancer Center, Palo Alto, California
Kaiser Permanente San Diego Mission Road, San Diego, California
BASS Cancer Center, Walnut Creek, California
Hartford Hospital (HH), Hartford, Connecticut
Sibley Memorial Hospital, Washington, District of Columbia
Boca Raton Regional Hospital, Boca Raton, Florida
Florida Cancer Specialists - South, Fort Myers, Florida
University of Florida - Jacksonville, Jacksonville, Florida
Miami Cancer Institute at Baptist Health, Inc., Miami, Florida
Florida Cancer Specialists North, Saint Petersburg, Florida
Comprehensive Hematology Oncology, Saint Petersburg, Florida
Moffitt Cancer Center, Tampa, Florida
Florida Cancer Specialists East, West Palm Beach, Florida
University of Illinois at Chicago, Chicago, Illinois
University of Chicago Medical Center, Chicago, Illinois
Captain James A. Lovell Federal Health Care Center, North Chicago, Illinois
Springfield Clinic Main Campus, Springfield, Illinois
Parkview Research Center at Parkview Regional Medical Center, Fort Wayne, Indiana
Franciscan Health, Indianapolis, Indiana
The University of Kansas Cancer Center - Westwood, Westwood, Kansas
Baptist Health Lexington, Lexington, Kentucky
Baptist Health Hamburg, Lexington, Kentucky
CHI Saint Joseph Cancer Center - East, Lexington, Kentucky
Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana
Ochsner Health Ochsner Cancer Center - Baton Rouge, Baton Rouge, Louisiana
Ochsner Clinic Foundation, New Orleans, Louisiana
New England Cancer Specialists, Westbrook, Maine
University of Maryland, Baltimore, Maryland
Johns Hopkins Bayview Medical Center, Baltimore, Maryland
Reliant Medical Group, Worcester, Massachusetts
Karmanos Cancer Institute, Detroit, Michigan
Missouri Baptist Medical Center, Saint Louis, Missouri
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
Roswell Park Cancer Institute, Buffalo, New York
Columbia University Irving Medical Center, New York, New York
Memorial Sloan Kettering Cancer Center, New York, New York
Northport VA Medical Center, Northport, New York
Cleveland Clinic, Cleveland, Ohio
Providence Portland Medical Center, Portland, Oregon
Providence St. Vincent Medical Center, Portland, Oregon
Kaiser Permanente Interstate Medical Office Central, Portland, Oregon
Oregon Health and Science University, Portland, Oregon
Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia, Pennsylvania
AHN Allegheny General Hospital, Pittsburgh, Pennsylvania
Medical University of South Carolina, Charleston, South Carolina
Lexington Medical Center, West Columbia, South Carolina
Tennessee Oncology Chattanooga, Chattanooga, Tennessee
University of Tennessee Medical Center, Knoxville, Tennessee
Sarah Cannon Research Institute, Nashville, Tennessee
SCRI Oncology Partners, Nashville, Tennessee
Tennessee Oncology, Nashville, Tennessee
The Center for Cancer and Blood Disorders, Fort Worth, Texas
Houston Methodist Hospital, Houston, Texas
University of Texas MD Anderson Cancer Center, Houston, Texas
USO - Texas Oncology - San Antonio, San Antonio, Texas
USO - Texas Oncology Gulf Coast, Sugar Land, Texas
USO - US Oncology Research Network, The Woodlands, Texas
The University of Vermont Medical Center Inc., Burlington, Vermont
University of Virginia Health System, Charlottesville, Virginia
VCU Health Adult Outpatient Pavillion, Richmond, Virginia
Swedish Cancer Institute - Edmonds, Edmonds, Washington
Swedish Medical Center, Seattle, Washington
Cancer Care Northwest - Vercler, Spokane Valley, Washington
Northwest Cancer Specialists PC, Vancouver, Washington
University Hospital and UW Health Clinics, Madison, Wisconsin
Medical College of Wisconsin, Milwaukee, Wisconsin
Tamworth Hospital, North Tamworth, New South Wales
Icon Cancer Centre Wesley, Auchenflower, Queensland
Sunshine Coast University Hospital, Birtinya, Queensland
ICON Cancer Centre - Kurralta Park, Kurralta Park, South Australia
Austin Health, Heidelberg, Victoria
Goulburn Valley Health, Shepparton, Victoria
Latrobe Regional Health, Traralgon, Victoria
Sir Charles Gairdner Hospital, Perth, Western Australia
Ordensklinikum Linz GmbH Elisabethinen, Linz, Oberösterreich
Medizinische Universität Graz, Graz, Steiermark
Klinik Floridsdorf, Wien, Not set
Antwerp University Hospital, Edegem, Antwerpen
CHIREC - site delta, Auderghem, Bruxelles-Capitale, Région De
UZ Leuven, Leuven, Vlaams-Brabant
AZ Delta vzw, Roeselare, West-Vlaanderen
Centro de Pesquisa Clínica do Instituto do Câncer do Ceará, Fortaleza, Ceará
Oncocentro de Minas Gerais, Belo Horizonte, Minas Gerais
Hospital de Cancer de Londrina, Londrina, Paraná
CTO - Centro de Tratamento Oncológico, Belem, Pará
Liga Norte Riograndense Contra o Câncer, Natal, Rio Grande Do Norte
Hospital Tacchini, Bento Gonçalves, Rio Grande Do Sul
Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul
Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, São Paulo
Centro de Pesquisa Sao Lucas, Campinas, São Paulo
Instituto D'Or de Pesquisa e Ensino (IDOR), Sao Paulo, São Paulo
Centro de Tratamento de Tumores Botafogo para Oncoclinicas Rio de Janeiro SA, Rio de Janeiro, Not set
Instituto D'Or Pesquisa e Ensino, Rio de Janeiro, Not set
Icesp - Instituto Do Câncer Do Estado de São Paulo, São Paulo, Not set
Hospital Santa Catarina - Paulista, São Paulo, Not set
Centro Paulista de Oncologia Clínica, São Paulo, Not set
K2 Oncology, Providencia, Región Metropolitana De Santiago
FALP, Santiago, Región Metropolitana De Santiago
Centro de Oncología de Precisión, Santiago, Región Metropolitana De Santiago
Bradfordhill, Santiago, Región Metropolitana De Santiago
Cancer Hospital Chinese Academy of Medical Science, Beijing, Beijing
China-Japan Friendship Hospital, Beijing, Beijing
Peking University People's Hospital, Beijing, Beijing
Beijing Cancer hospital, Beijing, Beijing
The Second Affiliated Hospital Chongqing Medical University, Chongqing, Chongqing
The First People's Hospital of Foshan, Foshan, Guangdong
Guangdong Provincial People's Hospital, Guangzhou, Guangdong
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong
Cancer Hospital of Shantou University Medical College, Shantou, Guangdong
ShenZhen People's Hospital, Shenzhen, Guangdong
Cancer Hospital Chinese Academy of Medical Sciences. Shenzhen Center, Shenzhen, Guangdong
Zhongshan Peoples Hospital, Zhongshan, Guangdong
Liuzhou People's Hospital, Liuzhou, Guangxi
Guangxi Medical University Affiliated Tumor Hospital, Nanning, Guangxi
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
Anyang Cancer Hospital, Anyang, Henan
The First Affiliated Hospital of Henan University of Science &Technology, Luoyang, Henan
Tongji Hospital Tongji Medical,Science & Technology, Wuhan, Hubei
Hubei Cancer Hospital, Wuhan, Hubei
Xiangya Hospital Central South University, Changsha, Hunan
Xiangya Hospital Central South University, Changsha, Hunan
Hunan Cancer Hospital, Changsha, Hunan
Hunan Cancer Hospital, Changsha, Hunan
ZhuZhou Central Hospital, Zhuzhou, Hunan
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu
Jilin Cancer Hospital, Changchun, Jilin
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi
Jinan Central Hospital, Jinan, Shandong
Shandong Cancer Hospital, Jinan, Shandong
Shanghai Chest Hospital, Shanghai, Shanghai
Fudan University Shanghai Cancer Center, Shanghai, Shanghai
Shanghai Pulmonary Hospital, Shanghai, Shanghai
West China Hospital, Sichuan University, Cheng Du, Sichuan
The Third People's Hospital of Chengdu (CDTPH), Chengdu, Sichuan
Sichuan Cancer hospital, Chengdu, Sichuan
The Second People's Hospital of Neijiang, Neijiang, Sichuan
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang
Zhejiang Cancer Hospital, Hangzhou, Zhejiang
Zhejiang Cancer Hospital, Hangzhou, Zhejiang
The Second Affiliated hospital of Zhejiang University school of medicine, Hangzhou, Zhejiang
Taizhou Hospital of Zhejiang Province, Linhai, Zhejiang
Nemocnice AGEL Ostrava - Vitkovice a.s., Ostrava, Ostrava Město
Fakultni nemocnice Bulovka, Prague, Praha 8
Centre Antoine-Lacassagne, Nice, Alpes-Maritimes
CHU Bordeaux Haut-Leveque, Pessac, Aquitaine
Assistance Publique Hôpitaux de Marseille - Hôpital Nord, Marseille, Bouches-du-Rhône
CHU de Toulouse - Hopital Larrey, Toulouse, Haute-Garonne
Centre Hospitalier Universitaire de Rennes - Hôpital Pontchaillou, Rennes, Ille-et-Vilaine
Chu Grenoble Alpes, La Tronche, Isère
Institut de Cancérologie de l'Ouest, Saint Herblain, Loire-Atlantique
Hôpital Robert Schuman, Vantoux, Lorraine
Institut Jean Godinot, Reims, Marne
Centre Leon Berard, Lyon Cedex08, Rhône-Alpes
Hospices Civils de Lyon - Hopital Louis Pradel, Bron, Rhône
Gustave Roussy, Villejuif, Val-de-Marne
Centre Hospitalier Universitaire de Poitiers, Poitiers, Vienne
Institut Curie, Paris, Not set
Groupe hospitalier Paris saint Joseph, Paris, Île-de-France
Hôpital Européen Georges Pompidou, Paris, Île-de-France
Thoraxklinik-Heidelberg gGmbH, Heidelberg, Baden-Württemberg
Robert Bosch Krankenhaus GmbH, Stuttgart, Baden-Württemberg
Universitaetsklinikum Tuebingen, Tübingen, Baden-Württemberg
Onkologiezentrum Donauwörth, Donauwörth, Bayern
Asklepios Fachkliniken München-Gauting, Gauting, Bayern
Klinikum Nürnberg Nord, Nürnberg, Bayern
MV-Zentrum für Onkologie und Hämatologie, Cologne, Nordrhein-Westfalen
Florence-Nightingale-Krankenhaus, Düsseldorf, Nordrhein-Westfalen
Evangelisches Krankenhaus Herne - Eickel, Herne, Nordrhein-Westfalen
Klinikum Köln-Merheim, Köln, Nordrhein-Westfalen
Krankenhaus Martha-Maria Halle-Dölau, Halle, Sachsen-Anhalt
Klinikum Chemnitz, Chemnitz, Sachsen
St. Elisabeth-Krankenhaus Leipzig, Leipzig, Sachsen
LungenClinic Grosshansdorf, Grosshansdorf, Schleswig-Holstein
HELIOS Klinikum Erfurt, Erfurt, Thüringen
Vivantes Klinikum im Friedrichshain - Landsberger Allee, Berlin, Not set
Evangelische Lungenklinik Berlin, Berlin, Not set
DRK Kliniken Berlin Mitte, Berlin, Not set
Franziskus-Hospital Harderberg, Georgsmarienhütte, Not set
Asklepios Klinik Harburg, Hamburg, Not set
University Hospital of Patras, Patras, Achaḯa
Agios Savvas Regional Cancer Hospital, Athens, Attikí
Errikos Dunant Hospital Center, Athens, Attikí
Thoracic General Hospital of Athens "I Sotiria", Athens, Attikí
University General Hospital of Heraklion, Heraklion, Irakleío
Agios Loukas Clinic, Thessaloniki, Kentrikí Makedonía
European Interbalkan Medical Center, Thessaloniki, Thessaloníki
University General Hospital of Larissa, Larissa, Thessalía
Farkasgyepui Tudogyogyintezet, Farkasgyepu, Veszprém
Országos Onkológiai Intézet, Budapest, Not set
Budapesti Uzsoki Utcai Kórház, Budapest, Not set
Savera Cancer & Multi Speciality Hospital, Patna, Bihar
Hemato Oncology Clinic, Ahmedabad, Gujarat
Malabar Cancer Centre - Thalassery, Thalassery, Kerala
Regional Cancer Centre - Thiruvananthapuram, Thiruvananthapuram, Kerala
Galaxy Superspeciality Hospital, Aurangabad, Maharashtra
Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, Maharashtra
Deenanath Mangeshkar Hospital & Research Centre, Pune, Maharashtra
Medipoint Hospitals Pvt. Ltd., Pune, Maharashtra
Pacific Medical College & Hospital, Udaipur, Rajasthan
Rajiv Gandhi Government General Hospital, Chennai, Tamil Nadu
Thangam Cancer Center - Namakkal, Namakkal, Tamil Nadu
Tata Memorial Centre - Homi Bhabha Cancer Hospital, Varanasi, Uttar Pradesh
Meir Medical Center, Kfar Saba, HaMerkaz
Sheba Medical Center, Ramat Gan, HaMerkaz
Rambam Health Care Campus, Haifa, HaTsafon
Shaare Zedek Medical Center, Jerusalem, Yerushalayim
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Emilia-Romagna
Ospedale San Gerardo-ASST Monza, Monza, Lombardia
ASST Grande Ospedale Metropolitano Niguarda, Milan, Milano
Azienda Ospedaliera Dei Colli, Naples, Napoli
Azienda Sanitaria Ospedaliera S Luigi Gonzaga, Orbassano, Piemonte
Instituto Tumori Giovanni Paolo II, Bari, Puglia
Istituto Nazionale Tumori Regina Elena, Rome, Roma
Policlinico "G. Rodolico", Catania, Sicilia
Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento, Verona, Veneto
Ospedale San Martino, Genova, Not set
Aichi Cancer Center Hospital, Nagoya, Aichi
National Cancer Center Hospital East, Kashiwa, Chiba
Hokkaido University Hospital, Sapporo, Hokkaido
Himeji Medical Center, Himeji, Hyogo
Kanazawa University Hospital, Kanazawa, Ishikawa
Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa
Kanagawa cancer center, Yokohama, Kanagawa
Miyagi Cancer Center, Natori, Miyagi
Niigata Cancer Center Hospital, Niigata-shi, Niigata
Kansai Medical University Hospital, Hirakata, Osaka
NHO Kinki Chuo Chest Medical Center, Sakai, Osaka
Saitama Medical University International Medical Center, Hidaka, Saitama
Shizuoka Cancer Center, Nagaizumi-cho,Sunto-gun, Shizuoka
Tokyo Metropolitan Komagome Hospital, Bunkyo ku, Tokyo
Juntendo University Hospital, Bunkyo-ku, Tokyo
The Cancer Institute Hospital of JFCR, Koto, Tokyo
Tottori University Hospital, Yonago, Tottori
Kyushu University Hospital, Fukuoka, Not set
University Hospital,Kyoto Prefectural University of Medicine, Kyoto, Not set
Wakayama Medical University Hospital, Wakayama, Not set
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do [Chungbuk]
The Catholic University of Korea, Incheon St. Mary's Hospital, Bupyeong-gu, Incheon-gwangyeoksi [Incheon]
Chonnam National University Hwasun Hospital, Hwasun-gun, Jeonranamdo
National Cancer Center, Goyang-si, Kyǒnggi-do
Seoul National University Bundang Hospital, Seongnam, Kyǒnggi-do
The Catholic University Of Korea St. Vincent's Hospital, Suwon-si, Kyǒnggi-do
Pusan National University Yangsan Hospital, Yangsan, Kyǒngsangnam-do
Pusan National University Hospital, Busan, Pusan-Kwangyǒkshi
Gangnam Severance Hospital, Yonsei University Health System, Gangnam-gu, Seoul-teukbyeolsi [Seoul]
The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul]
Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul]
Konkuk University Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]
Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]
Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]
The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul]
The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul]
Korea University Guro Hospital, Seoul, Seoul-teukbyeolsi [Seoul]
Keimyung University Dongsan Hospital, Daegu, Taegu-Kwangyǒkshi
Kyungpook National University Chilgok Hospital, Deagu, Taegu-Kwangyǒkshi
Yeungnam Univeristy Medical Center, Nam-gu, Taegu-Kwangyǒkshi
Ziekenhuis St. Jansdal, Harderwijk, Gelderland
Amphia Ziekenhuis, locatie Breda Molengracht, Breda, Noord-Brabant
ETZ Elisabeth, Tilburg, Noord-Brabant
Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, Noord-Holland
Amsterdam UMC, locatie VUmc, Amsterdam, Noord-Holland
Isala, locatie Zwolle, Zwolle, Overijssel
St. Antonius Ziekenhuis, locatie Utrecht, Utrecht, Not set
Sorlandet Sykehus Arendal, Arendal, Aust-Agder
Drammen Sykehus, Vestre Viken HF, Drammen, Buskerud
Haukeland Universitetssjukehus, Bergen, Hordaland
Sykehuset Innlandet HF Gjøvik, Gjøvik, Oppland
Oslo universitetssykehus, Radiumhospitalet, Oslo, Not set
Wielkopolskie Centrum Pulmonologii i Torakochirurgii, Poznan, Wielkopolskie
One Day Med, Szczecin, Zachodniopomorskie
Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zaklad Opieki Zdrowotnej, Kielce, Świętokrzyskie
Centro Hospitalar E Universitário De Coimbra, Coimbra, Not set
Hospital da Luz Lisboa, Lisboa, Not set
Hospital CUF Porto, Porto, Not set
Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, Not set
Lotus-Med, Bucharest, București
SC Memorial Healthcare International SRL, Bucharest, București
Ovidius Clinical Hospital OCH, Ovidiu, Constanța
Institutul Oncologic, Cluj, Not set
Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica, Banska Bystrica, Banskobystrický Kraj
Univerzitná nemocnica Bratislava - Nemocnica Ružinov, Bratislava, Bratislavský Kraj
Vychodoslovensky Onkologicky ustav a.s., Kosice, Not set
CHUS - Hospital Clinico Universitario, Santiago de Compostela, A Coruña [La Coruña]
Hospital Universitari Son Espases, Palma, Balears [Baleares]
Parc de Salut Mar - Hospital del Mar, Barcelona, Barcelona [Barcelona]
Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]
Instituto Catalan de Oncologia - Hospital Duran i Reynals, Hospitalet, Barcelona [Barcelona]
Hospital Clínic de Barcelona, Barcelona, Catalunya [Cataluña]
Hospital Jerez de la Frontera, Jerez de la Frontera, Cádiz
Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas
Hospital General Universitario Gregorio Marañon, Madrid, Madrid, Comunidad De
Hospital Universitario Ramón y Cajal, Madrid, Madrid, Comunidad De
Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad De
Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcon, Madrid
Complejo Hospitalario de Navarra, Pamplona, Navarra
Hospital Clinico de Valencia, Valencia, Valenciana, Comunitat
Hospital Infanta Cristina, Badajoz, Not set
H.R.U Málaga - Hospital General, Málaga, Not set
Hospital Universitario Virgen Del Rocio, Sevilla, Not set
Hospital Clínico Universitario Lozano Blesa, Zaragoza, Not set
Sahlgrenska Universitetssjukhuset Östra, Göteborg, Västra Götalands Län [se-14]
Kantonsspital Baden, Baden, Not set
HFR Fribourg - Hôpital Cantonal, Fribourg, Not set
Changhua Christian Hospital, Changhua County, Changhua
Hualien Tzu Chi Medical Center, Hualien City, Hualien
Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist, Kaohsiung
Far Eastern Memorial Hospital, New Taipei City, New Taipei
New Taipei Municipal TuCheng Hospital, New Taipei City, New Taipei
Chung Shan Medical University Hospital, Taichung City, Taichung
Chi Mei Medical Center, Tainan City, Tainan
Chi Mei Hospital - Liouying Branch, Tainan City, Tainan
National Taiwan University Cancer Center (NTUCC), Taipei City, Taipei
National Taiwan University Hospital Yun-Lin Branch Dou-Liou Region, Douliu City, Yunlin
Buddhist Dalin Tzu Chi General Hospital, Chiayi, Not set
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Not set
E-Da hospital, Kaohsiung, Not set
Taichung Veterans General Hospital, Taichung, Not set
National Cheng Kung University Hospital, Tainan, Not set
National Taiwan University Hospital, Taipei, Not set
Taipei Veterans General Hospital, Taipei, Not set
Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Not set
Marmara Universitesi Pendik Egitim Arastirma Hastanesi, Pendik, İstanbul
Sakarya University School of Medicine, Adapazari, Sakarya
Baskent University Dr. Turgut Noyan Research and Training Center, Adana, Not set
Adana City Hospital, Adana, Not set
Antalya Egitim ve Arastırma Hastanesi, Antalya, Not set
Trakya University, Edirne, Not set
Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi, Gaziantep, Not set
İ.A.Ü VM Medical Park Florya Hastanesi, Istanbul, Not set
Izmir Atatürk Training and Research Hospital, Izmir, Not set
Samsun Medical Park Hastanesi, Samsun, Not set
University Hospitals Sussex NHS Foundation Trust, East Sussex, Brighton And Hove
Torbay Hospital, Torquay, Devon
Huddersfield Royal Infirmary, Huddersfield, England
Royal Marsden Hospital (Chelsea), London, Kensington And Chelsea
Royal Marsden Hospital (Sutton), London, Sutton
Heartlands Hospital, Birmingham, Not set
The Christie NHS Foundation Trust, Manchester, Not set
Conditions: Carcinoma, Non-Small-Cell Lung
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS
Recruiting
The purpose of the study is to assess the efficacy of durvalumab plus tremelimumab in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy in metastatic NSCLC patients with non-squamous histology who have mutations and/or co-mutations in STK11, KEAP1, or KRAS.
The purpose of the study is to assess the efficacy of durvalumab plus tremelimumab in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy in metastatic NSCLC patients with non-squamous histology who have mutations and/or co-mutations in STK11, KEAP1, or KRAS. Read Less
Gender:
ALL
Ages:
Between 18 years and 130 years
Trial Updated:
07/18/2025
Locations: Research Site, Birmingham, Alabama +104 locations
Research Site, Birmingham, Alabama
Research Site, Anchorage, Alaska
Research Site, Chandler, Arizona
Research Site, Tucson, Arizona
Research Site, Irvine, California
Research Site, La Jolla, California
Research Site, Loma Linda, California
Research Site, Los Alamitos, California
Research Site, Los Angeles, California
Research Site, Los Angeles, California
Research Site, Redding, California
Research Site, Santa Monica, California
Research Site, Denver, Colorado
Research Site, Wheat Ridge, Colorado
Research Site, Washington, District of Columbia
Research Site, Washington, District of Columbia
Research Site, Fort Lauderdale, Florida
Research Site, Jupiter, Florida
Research Site, Ocala, Florida
Research Site, Orlando, Florida
Research Site, Saint Petersburg, Florida
Research Site, Tampa, Florida
Research Site, Tampa, Florida
Research Site, Albany, Georgia
Research Site, Atlanta, Georgia
Research Site, Atlanta, Georgia
Research Site, Atlanta, Georgia
Research Site, Atlanta, Georgia
Research Site, Columbus, Georgia
Research Site, Honolulu, Hawaii
Research Site, Carterville, Illinois
Research Site, Chicago, Illinois
Research Site, Chicago, Illinois
Research Site, Maywood, Illinois
Research Site, Urbana, Illinois
Research Site, Dyer, Indiana
Research Site, Evansville, Indiana
Research Site, Westwood, Kansas
Research Site, Lexington, Kentucky
Research Site, Louisville, Kentucky
Research Site, Bethesda, Maryland
Research Site, Jamaica Plain, Massachusetts
Research Site, Worcester, Massachusetts
Research Site, Detroit, Michigan
Research Site, Farmington Hills, Michigan
Research Site, Lansing, Michigan
Research Site, Traverse City, Michigan
Research Site, Saint Paul, Minnesota
Research Site, Kansas City, Missouri
Research Site, Kansas City, Missouri
Research Site, Saint Louis, Missouri
Research Site, Saint Louis, Missouri
Research Site, Billings, Montana
Research Site, Grand Island, Nebraska
Research Site, Lincoln, Nebraska
Research Site, Albany, New York
Research Site, Bronx, New York
Research Site, Bronx, New York
Research Site, Clifton Park, New York
Research Site, East Syracuse, New York
Research Site, Mineola, New York
Research Site, New Hyde Park, New York
Research Site, New York, New York
Research Site, New York, New York
Research Site, New York, New York
Research Site, New York, New York
Research Site, Northport, New York
Research Site, Shirley, New York
Research Site, Stony Brook, New York
Research Site, Syracuse, New York
Research Site, Westbury, New York
Research Site, Bismarck, North Dakota
Research Site, Cleveland, Ohio
Research Site, Cleveland, Ohio
Research Site, Cleveland, Ohio
Research Site, Columbus, Ohio
Research Site, Dayton, Ohio
Research Site, Maumee, Ohio
Research Site, Perrysburg, Ohio
Research Site, Toledo, Ohio
Research Site, Norman, Oklahoma
Research Site, Hershey, Pennsylvania
Research Site, Philadelphia, Pennsylvania
Research Site, Philadelphia, Pennsylvania
Research Site, Pittsburgh, Pennsylvania
Research Site, Providence, Rhode Island
Research Site, Sioux Falls, South Dakota
Research Site, Memphis, Tennessee
Research Site, Memphis, Tennessee
Research Site, Memphis, Tennessee
Research Site, Nashville, Tennessee
Research Site, Austin, Texas
Research Site, Dallas, Texas
Research Site, Dallas, Texas
Research Site, Denton, Texas
Research Site, Fort Worth, Texas
Research Site, Houston, Texas
Research Site, Houston, Texas
Research Site, Kingwood, Texas
Research Site, San Antonio, Texas
Research Site, San Antonio, Texas
Research Site, Charlottesville, Virginia
Research Site, Fairfax, Virginia
Research Site, Richmond, Virginia
Research Site, Milwaukee, Wisconsin
Conditions: Carcinoma, Non-Small-Cell Lung
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Recruiting
The purpose of this study is to assess if adding LY3537982 (olomorasib) in combination with standard of care anti-cancer drugs is more effective than standard of care in participants with untreated advanced NSCLC. NSCLC must have a change in a gene called KRAS G12C. Study participation, including follow-up, could last up to 3 years, depending on how you and your lung cancer are doing.
The purpose of this study is to assess if adding LY3537982 (olomorasib) in combination with standard of care anti-cancer drugs is more effective than standard of care in participants with untreated advanced NSCLC. NSCLC must have a change in a gene called KRAS G12C. Study participation, including follow-up, could last up to 3 years, depending on how you and your lung cancer are doing. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/18/2025
Locations: Clearview Cancer Institute, Huntsville, Alabama +426 locations
Clearview Cancer Institute, Huntsville, Alabama
Banner MD Anderson Cancer Center, Gilbert, Arizona
Banner University Medical Center Phoenix, Phoenix, Arizona
The University of Arizona Cancer Center - North Campus, Tucson, Arizona
Highlands Oncology Group, Springdale, Arkansas
Cedars-Sinai Medical Center, Los Angeles, California
Mercy Cancer Center, Merced, California
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
BASS Cancer Center, Walnut Creek, California
USO - Rocky Mountain Cancer Centers, Lone Tree, Colorado
Yale University School of Medicine, New Haven, Connecticut
Sibley Memorial Hospital, Washington, District of Columbia
Millennium Oncology Research Clinic, Hollywood, Florida
University of Florida - Jacksonville, Jacksonville, Florida
Miami Cancer Institute at Baptist Health, Inc., Miami, Florida
Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala, Ocala, Florida
Comprehensive Hematology Oncology, Saint Petersburg, Florida
Tampa General Hospital, Tampa, Florida
University Cancer & Blood Center, LLC, Athens, Georgia
Winship Cancer Institute, Emory University, Atlanta, Georgia
University of Illinois at Chicago, Chicago, Illinois
University of Chicago Hospital, Chicago, Illinois
Springfield Clinic Main Campus, Springfield, Illinois
Parkview Research Center at Parkview Regional Medical Center, Fort Wayne, Indiana
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana
Franciscan Health, Indianapolis, Indiana
Community Cancer Center North, Indianapolis, Indiana
The University of Kansas Cancer Center - Westwood, Westwood, Kansas
CHI Saint Joseph Cancer Center - East, Lexington, Kentucky
University of Kentucky Chandler Medical Center, Lexington, Kentucky
Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana
USO - Maryland Oncology Hematology, Annapolis, Maryland
Johns Hopkins Bayview Medical Center, Baltimore, Maryland
Boston Medical Center, Boston, Massachusetts
Lahey Hospital & Medical Center, Burlington, Massachusetts
University of Michigan, Ann Arbor, Michigan
Karmanos Cancer Institute, Detroit, Michigan
The Cancer & Hematology Centers, Grand Rapids, Michigan
Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis, Minnesota
HealthPartners Cancer Research Center, Saint Paul, Minnesota
North Mississippi Hematology and Oncology Associates, Tupelo, Mississippi
Oncology Hematology Associates, Springfield, Missouri
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
The Valley Hospital, Inc., Paramus, New Jersey
University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico
Maimonides Cancer Center, Brooklyn, New York
Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success, New York
Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola, New York
Laura and Isaac Perlmutter Cancer Center, New York, New York
Manhattan Eye, Ear and Throat Hospital, New York, New York
Memorial Sloan Kettering Cancer Center, New York, New York
Clinical Research Alliance, Westbury, New York
University of North Carolina Medical Center, Chapel Hill, North Carolina
Duke Cancer Institute, Durham, North Carolina
UNC REX Cancer Center, Raleigh, North Carolina
USO - Oncology Hematology Care, Cincinnati, Ohio
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus, Ohio
USO - Oncology Associates of Oregon, Eugene, Oregon
Asante Rogue Regional Medical Center, Medford, Oregon
Providence Portland Medical Center, Portland, Oregon
Providence St. Vincent Medical Center, Portland, Oregon
Kaiser Permanente Interstate Medical Office Central, Portland, Oregon
USO - Alliance Cancer Specialists, PC, Horsham, Pennsylvania
Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia, Pennsylvania
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
Lifespan Cancer Institute, Providence, Rhode Island
Medical University of South Carolina, Charleston, South Carolina
Prisma Health Cancer Institute, Greenville, South Carolina
Lexington Medical Center, West Columbia, South Carolina
Tennessee Oncology Chattanooga, Chattanooga, Tennessee
University of Tennessee Medical Center, Knoxville, Tennessee
Baptist Memorial Hospital-Memphis, Memphis, Tennessee
Tennessee Oncology, Nashville, Tennessee
USO - US Oncology Research Network, Nashville, Tennessee
USO - Texas Oncology, Austin, Texas
William Beaumont Army Medical Center, Fort Bliss, Texas
Brooke Army Medical Center, Fort Sam Houston, Texas
Houston Methodist Hospital, Houston, Texas
University of Texas MD Anderson Cancer Center, Houston, Texas
USO - Texas Oncology, Webster, Texas
The University of Vermont Medical Center Inc., Burlington, Vermont
University of Virginia Health System, Charlottesville, Virginia
USO - Virginia Cancer Specialists, Fairfax, Virginia
VCU Health Adult Outpatient Pavillion, Richmond, Virginia
Kadlec Clinic Hematology and Oncology, Kennewick, Washington
Swedish Medical Center, Seattle, Washington
VA Puget Sound Health Care System, Seattle, Washington
USO - Northwest Cancer Specialists, Vancouver, Washington
SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison, Wisconsin
Gosford Hospital, Gosford, New South Wales
Icon Cancer Centre Wesley, Auchenflower, Queensland
Sunshine Coast University Hospital, Birtinya, Queensland
Mackay Base Hospital, Mackay, Queensland
Gold Coast University Hospital, Southport, Queensland
The Townsville Hospital, Townsville, Queensland
Royal Adelaide Hospital, Adelaide, South Australia
Ballarat Health Services, Ballarat Central, Victoria
St Vincent's Hospital, Melbourne, Victoria
Goulburn Valley Health, Shepparton, Victoria
Sir Charles Gairdner Hospital, Perth, Western Australia
Ordensklinikum Linz GmbH Elisabethinen, Linz, Oberösterreich
Landeskrankenhaus Feldkirch, Feldkirch, Vorarlberg
Klinik Floridsdorf, Wien, Not set
ZNA Middelheim, Antwerp, Antwerpen
AZ Sint-Maarten, Mechelen, Antwerpen
Clinique Saint Pierre, Ottignies, Brabant Wallon
CHIREC - site delta, Auderghem, Bruxelles-Capitale, Région De
Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godinne, Yvoir, Namur
UZ Gent, Gent, Oost-Vlaanderen
UZ Leuven, Leuven, Vlaams-Brabant
AZ Sint-Jan Brugge-Oostende AV, Brugge, West-Vlaanderen
AZ Groeninge Campus Kennedylaan, Kortrijk, West-Vlaanderen
AZ Glorieux Ronse, Ronse, Not set
Clinica Amo - Rio Vermelho, Salvador, Bahia
Centro de Pesquisa Clínica do Instituto do Câncer do Ceará, Fortaleza, Ceará
Sirio-Libanes Brasilia - Centro de Oncologia - Asa Sul, Brasilia, Distrito Federal
Hospital Brasilia, Lago sul, Distrito Federal
CEDOES, Vitória, Espírito Santo
Hospital São Domingos, Bequimao, Maranhão
Oncocentro de Minas Gerais, Belo Horizonte, Minas Gerais
Oncominas, Pouso Alegre, Minas Gerais
Hospital Universitário Evangélico Mackenzie, Curitiba, Paraná
Hospital de Cancer de Londrina, Londrina, Paraná
Liga Norte Riograndense Contra o Câncer, Natal, Rio Grande Do Norte
Hospital Tacchini, Bento Gonçalves, Rio Grande Do Sul
ONCOSITE - Centro de Pesquisa Clinica em Oncologia, Ijui, Rio Grande Do Sul
Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul
Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, São Paulo
Faculdade de Medicina do ABC, Santo André, São Paulo
Hospital Sírio Libanês, Sao Paulo, São Paulo
Hospital BP, Sao Paulo, São Paulo
Hospital Paulistano, Sao Paulo, São Paulo
Instituto D'Or de Pesquisa e Ensino (IDOR), Sao Paulo, São Paulo
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo
COE Ensino e Pesquisa, São José dos Campos, São Paulo
Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA, Rio de Janeiro, Not set
Centro de Tratamento de Tumores Botafogo para Oncoclinicas Rio de Janeiro SA, Rio de Janeiro, Not set
Instituto D'Or Pesquisa e Ensino, Rio de Janeiro, Not set
Icesp - Instituto Do Câncer Do Estado de São Paulo, São Paulo, Not set
Hospital Santa Catarina - Paulista, São Paulo, Not set
Centro Paulista de Oncologia Clínica, São Paulo, Not set
Núcleo de Pesquisa Clínica da Rede São Camilo, São Paulo, Not set
Instituto de Assistência Médica ao Servidor Público Estadual - IAMSPE/HSPE-FMO Conhecer Centro de Oncolog -T, São Paulo, Not set
BC Cancer Abbotsford, Abbotsford, British Columbia
BC Cancer Vancouver, Vancouver, British Columbia
CIUSSS- saguenay-Lac-Saint-Jean, Chicoutimi, Quebec
Wannan Medical College Yijishan Hospital, Wuhu, Anhui
Cancer Hospital Chinese Academy of Medical Science, Beijing, Beijing
Beijing Cancer hospital, Beijing, Beijing
Fujian Cancer Hospital, Fuzhou, Fujian
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong
Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong
Liuzhou People's Hospital, Liuzhou, Guangxi
Hainan General Hospital, Haikou, Hainan
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
Tongji Hospital Tongji Medical,Science & Technology, Wuhan, Hubei
Wuhan Union Hospital, Wuhan, Hubei
Renmin Hospital of Wuhan University, Wuhan, Hubei
Xiangyang Central Hospital, Xiangyang, Hubei
Hunan Cancer Hospital, Changsha, Hunan
Hunan Cancer Hospital, Changsha, Hunan
ZhuZhou Central Hospital, Zhuzhou, Hunan
The First People's Hospital of Changzhou, Changzhou, Jiangsu
Nanjing First Hospital, Nanjing, Jiangsu
Nantong Tumor Hospital, Nantong, Jiangsu
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi
Jilin Cancer Hospital, Changchun, Jilin
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi
Jinan Central Hospital, Jinan, Shandong
Shandong Cancer Hospital, Jinan, Shandong
LinYi Cancer Hospital, Linyi, Shandong
Shanghai Chest Hospital, Shanghai, Shanghai
West China Hospital, Sichuan University, Cheng Du, Sichuan
The Third People's Hospital of Chengdu (CDTPH), Chengdu, Sichuan
Sichuan Cancer hospital, Chengdu, Sichuan
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin
The First Affiliated Hospital of Xinjiang Medical University, Urumchi, Xinjiang
Xinjiang Medical University Cancer Hospital - Urumqi, Urumqi, Xinjiang
The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang
Zhejiang Cancer Hospital, Hangzhou, Zhejiang
Taizhou Hospital of Zhejiang Province, Linhai, Zhejiang
Hwa Mei Hospital University of Chinese Academy of Sciences, Ningbo, Zhejiang
Yichang Central People's Hospital, Yichang, Not set
Nemocnice AGEL Ostrava - Vitkovice a.s., Ostrava, Ostrava Město
Fakultni nemocnice Bulovka, Prague, Praha 8
Roskilde University Hospital, Roskilde, Sjælland
Centre Antoine-Lacassagne, Nice, Alpes-Maritimes
Nouvel Hôpital Civil (NHC), Strasbourg, Alsace
CHU Bordeaux Haut-Leveque, Pessac, Aquitaine
CHU de Toulouse - Hopital Larrey, Toulouse, Haute-Garonne
Hôpital Foch, Suresnes, Hauts-de-Seine
Centre Hospitalier Universitaire de Rennes - Hôpital Pontchaillou, Rennes, Ille-et-Vilaine
Institut de Cancérologie de l'Ouest, Saint Herblain, Loire-Atlantique
Hôpital Robert Schuman, Vantoux, Lorraine
Institut Jean Godinot, Reims, Marne
Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois, Vandoeuvre lès Nancy, Meurthe-et-Moselle
CHU Lille - Institut Coeur Poumon, Lille Cedex, Nord
Centre Hospitalier intercommunal de Toulon La Seyne sur Mer, Toulon, Provence-Alpes-Côte-d'Azur
Centre Leon Berard, Lyon Cedex08, Rhône-Alpes
Hospices Civils de Lyon - Hopital Louis Pradel, Bron, Rhône
Gustave Roussy, Villejuif, Val-de-Marne
Sainte Catherine Institut du Cancer Avignon Provence, Avignon, Vaucluse
Centre Hospitalier Universitaire de Poitiers, Poitiers, Vienne
Institut Curie, Paris, Not set
Universitaetsklinikum Freiburg, Freiburg, Baden-Württemberg
Thoraxklinik-Heidelberg gGmbH, Heidelberg, Baden-Württemberg
Universitaetsklinikum Tuebingen, Tübingen, Baden-Württemberg
Onkologiezentrum Donauwörth, Donauwörth, Bayern
Asklepios Fachkliniken München-Gauting, Gauting, Bayern
Klinikum Nürnberg Nord, Nürnberg, Bayern
MV-Zentrum für Onkologie und Hämatologie, Cologne, Nordrhein-Westfalen
Universitätsklinikum Münster - Albert Schweitzer Campus, Münster, Nordrhein-Westfalen
Krankenhaus Martha-Maria Halle-Dölau, Halle, Sachsen-Anhalt
Klinikum Chemnitz, Chemnitz, Sachsen
LungenClinic Grosshansdorf, Grosshansdorf, Schleswig-Holstein
HELIOS Klinikum Erfurt, Erfurt, Thüringen
Evangelische Lungenklinik Berlin, Berlin, Not set
Charité Campus Virchow-Klinikum, Berlin, Not set
Helios Klinikum Emil von Behring Berlin-Zehlendorf, Berlin, Not set
Franziskus-Hospital Harderberg, Georgsmarienhütte, Not set
Hämato-Onkologie Hamburg, Prof. Laack und Partner, Hamburg, Not set
Asklepios Klinik Harburg, Hamburg, Not set
University Hospital of Patras, Patras, Achaḯa
Agios Savvas Regional Cancer Hospital, Athens, Attikí
Errikos Dunant Hospital Center, Athens, Attikí
Sotiria Thoracic Diseases Hospital of Athens, Athens, Attikí
Attikon General University Hospital, Chaidari, Attikí
University General Hospital of Heraklion, Heraklion, Irakleío
"Theagenio" Cancer Hospital of Thessaloniki, Thessaloniki, Kentrikí Makedonía
European Interbalkan Medical Center, Thessaloniki, Thessaloníki
G. Papanikolaou General Hospital, Thessaloniki, Thessaloníki
Bacs-Kiskun Megyei Korhaz, Kecskemét, Bács-Kiskun
Országos Korányi Pulmonológiai Intézet, Budapest, Pest
Farkasgyepui Tudogyogyintezet, Farkasgyepu, Veszprém
Országos Onkológiai Intézet, Budapest, Not set
Budapesti Uzsoki Utcai Kórház, Budapest, Not set
Mahatma Gandhi Cancer Hospital and Research Institute, Visakhapatnam, Andhra Pradesh
Hemato Oncology Clinic, Ahmedabad, Gujarat
KLES Dr. Prabhakar Kore Hospital & M.R.C, Belagavi, Karnataka
SRV Hospitals, Bengaluru, Karnataka
Regional Cancer Centre - Thiruvananthapuram, Thiruvananthapuram, Kerala
Krishna Institute of Medical Sciences - Karad, Karad, Maharashtra
Kolhapur Cancer Centre Private Limited, Kolhapur, Maharashtra
Tata Memorial Hospital, Mumbai, Maharashtra
HCG Manavata Cancer Centre, Nashik, Maharashtra
Grant Medical Foundation - Ruby Hall Clinic, Pune, Maharashtra
Sahyadri Super Speciality Hospital, Pune, Maharashtra
Lifepoint Multispeciality Hospital, Pune, Maharashtra
All India Institute of Medical Sciences, Bhubaneswar, Odisha
Pacific Medical College & Hospital, Udaipur, Rajasthan
Ashwin Hospital, Coimbatore, Tamil Nadu
Nizam's Institute of Medical Sciences, Hyderabad, Telangana
Tata Memorial Centre - Homi Bhabha Cancer Hospital, Varanasi, Uttar Pradesh
Jawaharlal Institute Of Postgraduate Medical Education And Research, Puducherry, Not set
Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania
Fondazione Policlinico Universitario Agostino Gemelli, Roma, Lazio
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia
Instituto Tumori Giovanni Paolo II, Bari, Puglia
Istituto Nazionale Tumori Regina Elena, Rome, Roma
Policlinico "G. Rodolico", Catania, Sicilia
Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento, Verona, Veneto
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Not set
Istituto Oncologico Veneto IRCCS, Padova, Not set
Ospedale di Circolo e Fondazione Macchi Varese, Varese, Not set
Aichi Cancer Center Hospital, Nagoya, Aichi
National Cancer Center Hospital East, Kashiwa, Chiba
National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime
National Hospital Organization Asahikawa Medical Center, Asahikawa, Hokkaido
Hokkaido University Hospital, Sapporo, Hokkaido
Himeji Medical Center, Himeji, Hyogo
Kobe City Medical Center General Hospital, Kobe, Hyogo
Ibaraki Prefectural Central Hospital, Kasama, Ibaraki
Kanazawa University Hospital, Kanazawa, Ishikawa
Kanagawa Cardiovascular and Respiratory Center, Yokohama, Kanagawa
Kanagawa cancer center, Yokohama, Kanagawa
Miyagi Cancer Center, Natori, Miyagi
Niigata Cancer Center Hospital, Niigata-shi, Niigata
Kansai Medical University Hospital, Hirakata, Osaka
Kindai University Hospital- Osakasayama Campus, Osakasayama, Osaka
National Hospital Organization Kinki-chuo Chest Medical Center, Sakai, Osaka
Saitama Medical University International Medical Center, Hidaka, Saitama
Shizuoka Cancer Center, Nagaizumi-cho,Sunto-gun, Shizuoka
Tochigi Cancer Center, Utsunomiya, Tochigi
Tokyo Metropolitan Komagome Hospital, Bunkyo ku, Tokyo
Juntendo University Hospital, Bunkyo-ku, Tokyo
Japanese Foundation for Cancer Research, Koto, Tokyo
Tottori University Hospital, Yonago, Tottori
National Hospital Organization Yamaguchi Ube Medical Center, Ube, Yamaguchi
National Hospital Organization Kyushu Cancer Center, Fukuoka, Not set
Kyushu University Hospital, Fukuoka, Not set
University Hospital,Kyoto Prefectural University of Medicine, Kyoto, Not set
Nagasaki University Hospital, Nagasaki, Not set
Okayama University Hospital, Okayama, Not set
Wakayama Medical University Hospital, Wakayama, Not set
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do [Chungbuk]
Chonnam National University Hwasun Hospital, Hwasun, Jeonranamdo
National Cancer Center, Goyang-si, Kyǒnggi-do
The Catholic University Of Korea St. Vincent's Hospital, Suwon-si, Kyǒnggi-do
Pusan National University Yangsan Hospital, Yangsan, Kyǒngsangnam-do
Gangnam Severance Hospital, Yonsei University Health System, Gangnam-gu, Seoul-teukbyeolsi [Seoul]
Korea University Anam Hospital, Seoul, Seoul-teukbyeolsi [Seoul]
Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul]
Hanyang University Seoul Hospital, Seoul, Seoul-teukbyeolsi [Seoul]
Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]
Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]
The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul]
Korea University Guro Hospital, Seoul, Seoul-teukbyeolsi [Seoul]
Keimyung University Dongsan Hospital, Daegu, Taegu-Kwangyǒkshi
Kyungpook National University Chilgok Hospital, Deagu, Taegu-Kwangyǒkshi
Health Pharma Professional Research S.A. de C.V:, Ciudad de México, Distrito Federal
Centro Onco-Hematológico Roma (COHR), Mexico City, Distrito Federal
Higiea Oncologia, Mexico City, Distrito Federal
Preparaciones Oncológicas S.C., León, Guanajuato
CIO - Centro de Inmuno-Oncología de Occidente, Guadalajara, Jalisco
PanAmerican Clinical Research - Guadalajara, Guadalajara, Jalisco
Actualidad Basada en la Investigación del Cáncer, Guadalajara, Jalisco
Renati Innovation, Guadalajara, Jalisco
Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Monterrey, Nuevo León
Avix Investigación Clinica, S.C., Monterrey, Nuevo León
Oncare - Unidad Valle, San Pedro Garza García, Nuevo León
Health Pharma Querétaro, Juriquilla, Querétaro
Centro de Investigacion Clinica de Oaxaca, Oaxaca, Not set
Clinica Integral Internacional de Oncología, Puebla, Not set
Arké SMO S.A de C.V, Veracruz, Not set
Medische Centrum Leeuwarden, Leeuwarden, Fryslân
Ziekenhuis St. Jansdal, Harderwijk, Gelderland
Jeroen Bosch Hospital, Den Bosch, Noord-Brabant
ETZ Elisabeth, Tilburg, Noord-Brabant
Tergooiziekenhuizen, locatie Hilversum, Hilversum, Noord-Holland
Medisch Spectrum Twente, Enschede, Overijssel
Leids Universitair Medisch Centrum, Leiden, Zuid-Holland
Erasmus Medisch Centrum, Rotterdam, Zuid-Holland
St. Antonius Ziekenhuis, locatie Utrecht, Utrecht, Not set
Akershus Universitetssykehus, Lørenskog, Akershus
Drammen Sykehus, Vestre Viken HF, Drammen, Buskerud
Haukeland Universitetssjukehus, Bergen, Hordaland
Sykehuset Innlandet HF Gjøvik, Gjøvik, Oppland
Stavanger Universitetssykehus, Stavanger, Rogaland
St. Olavs Hospital, Trondheim, Sør-Trøndelag
Oslo universitetssykehus, Radiumhospitalet, Oslo, Not set
MICS Centrum Medyczne Torun, Torun, Kujawsko-pomorskie
One Day Med, Szczecin, Zachodniopomorskie
Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zaklad Opieki Zdrowotnej, Kielce, Świętokrzyskie
Champalimaud Foundation, Lisbon, Lisboa
Hospital Pulido Valente, Lisbon, Lisboa
Centro Hospitalar E Universitário De Coimbra, Coimbra, Not set
Hospital da Luz Lisboa, Lisboa, Not set
Centro Hospitalar do Porto - Hospital de Santo António, Porto, Not set
Hospital CUF Porto, Porto, Not set
Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, Not set
Lotus-Med, Bucharest, București
SC Memorial Healthcare International SRL, Bucharest, București
Ovidius Clinical Hospital OCH, Ovidiu, Constanța
Centrul de Oncologie "Sfântul Nectarie", Craiova, Dolj
S C Oncocenter Oncologie Clinica S R L, Timișoara, Timiș
Cabinet Medical Oncomed, Timișoara, Timiș
Gral Medical Diagnostic Center, București, Not set
Institutul Oncologic, Cluj, Not set
CHUAC-Hospital Teresa Herrera, A Coruña, A Coruña [La Coruña]
CHUS - Hospital Clinico Universitario, Santiago de Compostela, A Coruña [La Coruña]
Hospital Universitari Son Espases, Palma, Balears [Baleares]
Parc de Salut Mar - Hospital del Mar, Barcelona, Barcelona [Barcelona]
Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]
Instituto Catalan de Oncologia - Hospital Duran i Reynals, Hospitalet, Barcelona [Barcelona]
OSI Ezkerraldea-Enkarterri-Cruces - Hospital Universitario Cruces, Barakaldo, Bizkaia
Complejo Asistencial Universitario de León - Hospital de León, León, Castilla Y León
Hospital Universitari Dexeus, Barcelona, Catalunya [Cataluña]
Hospital Jerez de la Frontera, Jerez de la Frontera, Cádiz
Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas
Hospital Universitario Ramón y Cajal, Madrid, Madrid, Comunidad De
Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad De
Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcon, Madrid
Complejo Hospitalario de Navarra, Pamplona, Navarra
Hospital Clinico de Valencia, Valencia, Valenciana, Comunitat
Hospital Infanta Cristina, Badajoz, Not set
H.R.U Málaga - Hospital General, Málaga, Not set
Hospital Universitario Virgen Del Rocio, Sevilla, Not set
Hospital Clínico Universitario Lozano Blesa, Zaragoza, Not set
Mälarsjukhuset, Eskilstuna, Södermanlands Län [se-04]
Västmanlands Sjukhus Västerås, Västerås, Västmanlands Län [se-19]
CHUV (centre hospitalier universitaire vaudois), Lausanne, Vaud
Kantonsspital Winterthur, Winterthur, Not set
UniversitätsSpital Zürich, Zürich, Not set
Changhua Christian Hospital, Changhua County, Changhua
National Taiwan University Hospital - Hsinchu branch, Zhu Bei City, Hsinchu
Hualien Tzu Chi Medical Center, Hualien City, Hualien
Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist, Kaohsiung
New Taipei Municipal TuCheng Hospital, New Taipei City, New Taipei
Chung Shan Medical University Hospital, Taichung City, Taichung
Chi Mei Medical Center, Tainan City, Tainan
Chi Mei Hospital - Liouying Branch, Tainan City, Tainan
National Taiwan University Cancer Center (NTUCC), Taipei City, Taipei
National Taiwan University Hospital Yun-Lin Branch Dou-Liou Region, Douliu City, Yunlin
Buddhist Dalin Tzu Chi General Hospital, Chiayi, Not set
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Not set
Taichung Veterans General Hospital, Taichung, Not set
National Cheng Kung University Hospital, Tainan, Not set
National Taiwan University Hospital, Taipei, Not set
Taipei Veterans General Hospital, Taipei, Not set
Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Not set
Adana Medical Park Seyhan Hastanesi, Adana, Not set
Adana City Hospital, Adana, Not set
Ankara Etlik City Hospital, Ankara, Not set
Abdurrahman Yurtaslan Ankara Oncology, education and Research Hospital, Ankara, Not set
Ankara Bilkent Şehir Hastanesi, Ankara, Not set
Akdeniz Universitesi Hastanesi, Antalya, Not set
Memorial Antalya Hospital, Antalya, Not set
Uludag Universitesi, Bursa, Not set
Dicle Üniversitesi, Diyarbakir, Not set
Bezmialem Vakf Üniversitesi, Istanbul, Not set
İ.A.Ü VM Medical Park Florya Hastanesi, Istanbul, Not set
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi, Istanbul, Not set
Ege Universitesi Hastanesi, Izmir, Not set
zmir Katip Çelebi Üniversitesi Atatürk Eitim Ve Aratrma Hastanesi, Izmir, Not set
Kocaeli Üniversitesi, Kocaeli, Not set
Ondokuz Mayıs Universitesi, Samsun, Not set
Aberdeen Royal Infirmary, Aberdeen, Aberdeen City
Ninewells Hospital and Medical School, Dundee, Dundee City
Huddersfield Royal Infirmary, Huddersfield, England
Weston Park Hospital, Sheffield, England
Cheltenham General Hospital, Cheltenham, Gloucestershire
Mount Vernon Hospital, Northwood, Hillingdon
St James's University Hospital, Leeds, Not set
The Christie NHS Foundation Trust, Manchester, Not set
New Cross Hospital, Wolverhampton, Not set
Conditions: Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Recruiting
This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of your blood. Once tumors have grown bigger in one place but haven't spread, they're called locally advanced. If your cancer has spread to other parts of your body, it's called metastatic. When a cancer has gotten so big it can't easily be removed or has spread to other parts of the body, it is called unresectable. These types of cancer are harder to... Read More
This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of your blood. Once tumors have grown bigger in one place but haven't spread, they're called locally advanced. If your cancer has spread to other parts of your body, it's called metastatic. When a cancer has gotten so big it can't easily be removed or has spread to other parts of the body, it is called unresectable. These types of cancer are harder to treat.
Participants in this study must have cancer that has come back or did not get better with treatment. Participants must have a solid tumor cancer that can't be treated with standard of care drugs.
This clinical trial uses an experimental drug called PF-08046050. PF-08046050 is a type of antibody-drug conjugate or ADC. ADCs are designed to stick to cancer cells and kill them. They may also stick to some normal cells.
This study will test the safety of PF-08046050 in participants with solid tumors that are hard to treat or have spread throughout the body.
This study has 5 different study parts. Part A and Part B of the study will find out how much PF-08046050 should be given to participants. Part C will use the information from Parts A and B to see if PF-08046050 is safe and if it works to treat certain solid tumor cancers. Part D of the study, together with information from Parts A and B, will find out how much PF-08046050 should be given to participants in combination with bevacizumab. Part E will use the information from Parts A, B, and D to see if PF-08046050 is safe in combination with bevacizumab and if it works to treat a certain solid tumor. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/17/2025
Locations: Mayo Clinic Hospital, Phoenix, Arizona +26 locations
Mayo Clinic Hospital, Phoenix, Arizona
City of Hope, Duarte, California
University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora, Colorado
University of Colorado Hospital/University of Colorado, Aurora, Colorado
Florida Cancer Specialists, Orlando, Florida
Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, Florida
Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore, Maryland
Beth Israel Deaconess Medical Center, Boston, Massachusetts
START Midwest, Grand Rapids, Michigan
Mayo Clinic Cancer Center, Rochester, Minnesota
Sarah Cannon Research Institute - Pharmacy, Nashville, Tennessee
SCRI Oncology Partners, Nashville, Tennessee
The University of Texas MD Anderson Cancer Center, Houston, Texas
South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas
South Texas Accelerated Research Therapeutics Mountain Region, West Valley City, Utah
The Ottawa Hospital, Ottawa, Ontario
University Health Network, Princess Margaret Hospital, Toronto, Ontario
McGill University Health Centre, Montreal, Quebec
Institut Gustave Roussy, Villejuif Cedex, Paris
Gustave Roussy, Villejuif, Not set
Netherlands Cancer Institute, Amsterdam, Not set
Institut Catala d'Oncologia - Hospital Duran i Reynals (ICO L'Hospitalet), L'Hospitalet de Llobregat, Catalunya [cataluña]
START Madrid-CIOCC_Hospital HM Sanchinarro, Madrid, Not set
Karolinska University Hospital, Solna, Not set
ApoEx NKS, Stockholm, Not set
The University of Edinburgh, Edinburgh, Not set
Sarah Cannon Research Institute UK, London, Not set
Conditions: Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Pancreatic Ductal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Small Cell Lung Carcinoma
1 - 12 of 41